WO1992022582A1 - Novel organ-specific plant promoter sequences - Google Patents

Novel organ-specific plant promoter sequences Download PDF

Info

Publication number
WO1992022582A1
WO1992022582A1 PCT/US1992/005170 US9205170W WO9222582A1 WO 1992022582 A1 WO1992022582 A1 WO 1992022582A1 US 9205170 W US9205170 W US 9205170W WO 9222582 A1 WO9222582 A1 WO 9222582A1
Authority
WO
WIPO (PCT)
Prior art keywords
gs3a
seq
promoter element
promoter
residue number
Prior art date
Application number
PCT/US1992/005170
Other languages
French (fr)
Inventor
Gloria M. Coruzzi
Janice W. Edwards
Elsbeth L. Walker
Timothy Brears
Original Assignee
The Trustees Of Rockefeller University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Trustees Of Rockefeller University filed Critical The Trustees Of Rockefeller University
Priority to EP92915003A priority Critical patent/EP0590086A4/en
Publication of WO1992022582A1 publication Critical patent/WO1992022582A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8222—Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8222—Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation
    • C12N15/8223—Vegetative tissue-specific promoters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8222—Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation
    • C12N15/8223—Vegetative tissue-specific promoters
    • C12N15/8225—Leaf-specific, e.g. including petioles, stomata
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8222—Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation
    • C12N15/8223—Vegetative tissue-specific promoters
    • C12N15/8227—Root-specific

Definitions

  • the present invention relates to novel plant organ- and cell- type specific transcriptional promoter nucleotide sequences which regulate the expression of genes encoding glutamine synthetase isoenzymes.
  • promoter sequence which responds to light and two promoter sequences which are selectively active in plant vascular elements have been cloned and characterized.
  • the promoter sequences of the invention may be used to control the expression of glutamine synthetase as well as genes encoding heterologous proteins, and may advantageously be used to render plants resistant to herbicides or viral or pathogen infection.
  • isoenzymes for many amino acid biosynthetic enzymes are located in the cytosol, as well as in the mitochondria or chloroplasts. The significance of this multiplicity and compartmentalization of plant isoenzymes has yet to be fully understood. The relative function of many amino acid biosynthetic isoenzymes has been difficult to assess due to inadequate fractionation of organelle and cytoplasm
  • GS glutamine synthetase
  • chloroplast GS2 In pea, the single nuclear gene for chloroplast GS2 is expressed predominantly in leaves in a light-dependent fashion (Tingey et al., 1988, J. Bio. Chem. 263:9651-9657; Edwards and Coruzzi, 1989, Plant Cell 1:241-248).
  • the role of chloroplast GS2 in the reassimilation of photorespiratory ammonia is supported by the analysis of mutants in barley (Wallsgrove et al., 1987, Plant Physiol. 83:155-158), and is substantiated by gene expression studies in pea (Edwards and Coruzzi, 1989, Plant Cell 1:241-248).
  • PLANT PROMOTER/ENHANCER SEQUENCES A number of plant promoter enhancer/sequences have been identified, including light-responsive promoter
  • rol A, B and C promoters have been identified in Agrobacterium rhizogenes (Schmulling et al., 1989, Plant Cell 1:665-670; Sugaya et al., 1989, Plant Cell Physiol. 30:649-654).
  • CiMV cauliflower mosaic virus
  • domain A (-90 to +8) was found to be particularly strong in root tissue, whereas expression conferred by domain B (-343 to -90) appeared to be strongest in the cotyledons of seeds and seedlings and in the vascular tissue of the hypocotyl
  • the present invention relates to novel plant organ-specific transcriptional promoter nucleotide sequences which regulate the expression of genes encoding glutamine
  • synthetase isoenzymes Specifically, promoter sequences were isolated from the nuclear gene for chloroplast GS2 glutamine synthetase and from two nuclear genes for
  • the present invention provides for the nucleic acid sequences of the GS2, GS3A and GS3B
  • the invention further provides for promoters
  • GS2 homologous to GS2, GS3A and GS3B, gene fusions comprising the novel glutamine synthetase promoters, and transgenic plants which comprise the promoters of the invention.
  • GS2 promoter directs expression in
  • GS3A was found to be selectively active in phloem; therefore, GS3A represents the first plant-derived, phloem-specific promoter element.
  • the GS2, GS3A, and GS3B promoter sequences may be used to control the
  • tissue-specific expression of a desired gene product presents a wide range of potential applications for the promoter sequences of the invention, including, but not limited to, the manipulation of nutritional requirements and the induction of resistance to herbicides or pathogens. 3.1. ABBREVIATIONS
  • transgenic plant a plant which has incorporated a foreign gene into its genome
  • transgene transgenic sequence: a foreign gene which has been incorporated into a transgenic plant
  • GUS contains 1.5 kb of the gene for chloroplast GS2 in a translational fusion with the GUS gene of pBI101.2.
  • B) pGS3A cy -GUS contains 1.01 kb of the gene for cytosolic GS3A in a translational fusion with the GUS gene of pBHOl.
  • a 3' polyadenylation region from the nopaline synthase gene is present in both GS-GUS constructs and is denoted with diagonal stripes. The white areas represent the 5'
  • E EcoRI
  • H HincII
  • Bg BglII
  • Restriction sites in parenthesis indicate original sites in plant genes which were destroyed in plasmid construction.
  • FIG. 1 Histochemical localization of GUS activity in cross sections of mature transgenic tobacco plants.
  • Panels A-D represent sections from pGSct-GUS transformants
  • Panels E-H represent sections from pGS3A cy -GUS transformants: E) leaf cross section, F) leaf midrib cross section, G) root cross section, H) stem cross section.
  • FIG. 1 Histochemical localization of GUS activity in whole mounts of 7 day-old transgenic tobacco seedlings; A) pGS2 ct -GUS transformant. B)- pGS3A cy -GUS transformant. C) control, pBHOl transformant. Abbreviations: C -cotyledon, H - hypocotyl, L - leaf, R - root, V -vasculature.
  • GUS transformants C
  • pBHOl transformant which was dark-adapted for 4 days (lanes 1 and 3), and subsequently grown in continuous white light for 24 hrs.
  • GS3A promoter is shown from nucleotide -1832 relative to the start of transcription to the Bglll site extending to +107
  • -122 to -106 represent fragment a206 and the smallest defined sequence to bind the protein GS3A-F1 (SEQ. ID. NO.
  • GS3B subcloned into Bluescnpt ® SK + vectors Gene sequences are in upper case letters, vector and linker sequences are in lower case letters. Restriction sites destroyed in cloning are marked in parentheses. All restriction sites are underlined. Numbers refer to the nucleotides of GS promoter as specified in FIG. 5.
  • Figure 7 Identification of the transcriptional start site of the GS3A promoter. 5' SI nuclease analysis was undertaken on 10 ⁇ g of total RNA from leaves, roots, nodules and cotyledons. Oligonucleotide EW1 was used to prepare a labelled probe complementary to the GS3A mRNAs and also sequencing reactions on the non-coding strand. Lane 1: tRNA control; lane 2: leaf RNA; lane 3: root RNA; lane 4: nodule RNA; lane 5: cotyledon RNA. GATC are the sequencing
  • transcriptional start site (X) are indicated schematically (exact positions for these can be found in FIG. 5B) .
  • the sequence of the first 16 codons illustrate the nature of the fusion constructed. Codons 1 to 6 are derived from GS3A coding sequence, codons 7 to 11 are derived from polylinker sequence, codons 12 to 15 are derived from the GUS leader, and codon 16 is the GUS ATG.
  • transgenic tobacco GUS expression in tobacco seedlings.
  • Panels A and B cotyledons of transgenic constructions A28 and A10, which correspond to the longest and shortest deletions respectively.
  • Panel C A28 seedlings.
  • Panel D root tip of an A28 seedling.
  • Panels E and F 8 ⁇ m leaf sections of a mature A28 alfalfa transformant (panel E is counterstained with erythrosin) showing expression localized to phloem, v: vasculature; rh: root hairs.
  • Figure 10 Histochemical detection of GUS in
  • Panels A to D GUS expression in nodules of an A13 transformant at different stages of maturity (from between 2 and 5 weeks post-nodulation).
  • Panel E transverse section through an A13 nodule expressing GUS.
  • Panel F GUS expression: in an A13 leaf.
  • Panel G
  • Panel H GUS expression in A28 nodules.
  • Panel I nodules on the pBI101 transformed control.
  • Panels J, K, and L 8 ⁇ m nodule sections (counterstained with erythrosin) allowing the definition of the cell-type expression of GUS (A28
  • np nodule primordium
  • v vasculature
  • c cortical cells
  • m meristematic cells
  • s symbiotic zone
  • es early symbiotic zone
  • Is late symbiotic zone
  • sn nodule primordium
  • Panel A The GS3A promoter sequence immediately adjacent to the shortest 5' deletion (A10) extending from -132 to -94 is shown (SEQ. ID. NO. 2, numbers 1701 to 1739). The imperfect palindrome contained in this sequence is indicated by the arrows. Bars below the DNA sequence indicate the five DNA fragments spanning this region of the GS3A promoter which were used in mobility-shift assays:
  • a201 (-129 to -97; SEQ. ID. NO. 2, number 1704 to 1736);
  • a202 (-129 to -106; SEQ. ID. NO. 2, number 1704 to 1727); a206 (-122 to -106; SEQ. ID. NO. 2 number 1711 to 1727);
  • a230 (-173 to -114; SEQ. ID. NO. 2, number 1660 to 1719); a239 (-113 to -54; SEQ. ID. NO. 2, number 1720 to 1779).
  • fragment a230 and a239 indicate that these fragments extend laterally beyond the sequence shown to the positions indicated above.
  • Nuclear extracts used in these assays were prepared from mature, dark-adapted tobacco plants.
  • Panel B Repairment a202 (lanes 1-8), and fragment a206 (lanes 9-12) were used as probes in gel-molility assays using tobacco nuclear extracts. All lanes are from the same gel.
  • Lane 1 free a202 probe; lane 2: probe + extract; lane 3 : probe + extract + 10-fold molar excess of unlabelled a202; lane 4: probe + extract + 50-fold molar excess of unlabelled a202; lane 5: probe + extract + 10-fold molar excess of unlabelled a230; lane 6: probe + extract + 50-fold molar excess of unlabelled a230; lane 7: probe + extract + 10-fold molar excess of unlabelled a239; lane 8: probe + extract + 50-fold molar excess of unlabelled a239.
  • Lane 9 free a206 probe; lane 10: probe + extract; lane 11: probe + extract + 10-fold molar excess of unlabelled a206; lane 12: probe + extract + 50-fold molar excess of unlabelled a206. Lane 13: probe + extract + 10-fold molar excess of a202 competitor; lane 14: probe + extract + 50-fold molar excess of a202 competitor.
  • Panel C Fragment a201 was used as a probe in DNA mobility-shift assays again using tobacco nuclear extracts. All lanes are from the same gel.
  • Lane 1 free a201 probe; lane 2: probe + extract; lane 3: probe + extract + 25-fold molar excess of a GTl-binding tetrameric competitor; lane 4: probe + extract + 125-fold molar excess of the same competitor; lane 5: probe + extract + 25-fold molar excess of a mutant tetrameric competitor which does not bind GT1; lane 6: 125-fold molar excess of the same mutant competitor. In each case approximately 1 ng of probe was used corresponding to c. 10,000 counts per minute.
  • glutamine synthetase isoenzymes provides for (i) promoter elements such as GS2, GS3A and GS3B, which have nucleotide sequences substantially as depicted in FIG. 5A, 5B and 5C, respectively (SEQ. ID. NOS. 1, 2 and 3, respectively), or nucleotide sequences homologous thereto; (ii) gene fusions containing these promoter elements; (iii) methods for producing tissue-specific expression of
  • transgenic plants containing transgenes which include the promoter elements of the invention are based, in part, on the
  • cytosolic GS3 of Pisum sativum confer non-overlapping, cell-specific expression patterns to the beta-glucuronidase (GUS) reporter gene in transgenic tobacco plants (See
  • the promoter for chloroplast GS2 was observed to direct GUS expression within photosynthetic cell types (e.g. palisade parenchymal cells of the leaf blade, chlorenchymal cells of the midrib and stem, and in
  • transgenic tobacco system in a manner analogous to the light-regulated expression of the cognate gene for
  • chloroplast GS2 in pea These expression patterns may reflect the physiological role of the chloroplast GS2 isoform in the assimilation of ammonia generated by nitrite reduction and photorespiration.
  • the promoter for cytosolic GS3A was found to direct expression of GUS specifically within the phloem elements in all organs of mature plants. This phloem-specific expression pattern suggests that the cytosolic GS3A isoenzyme may function to generate glutamine for intercellular nitrogen transport. In germinating seedlings, the intense expression of the cytosolic GS3A isoenzyme may function to generate glutamine for intercellular nitrogen transport. In germinating seedlings, the intense expression of the
  • promoter elements associated with glutamine synthetase genes may be identified from any species of plant, bacteria, or virus using any method known in the art.
  • genomic DNA libraries may be screened for clones containing sequences homologous to known glutamine synthetase genes or, alternatively, glutamine synthetase promoter sequences.
  • cDNA clones corresponding to mRNA which encodes glutamine may be identified from any species of plant, bacteria, or virus using any method known in the art.
  • genomic DNA libraries may be screened for clones containing sequences homologous to known glutamine synthetase genes or, alternatively, glutamine synthetase promoter sequences.
  • oligonucleotide probes corresponding to known glutamine synthetase amino acid sequence may be used to identify homologous clones in a genomic DNA library using methods such as, for example, the method set forth in Benton and Davis (1977, Science 196:180) for bacteriophage
  • Retrieved clones may then be analyzed by restriction-fragment mapping and sequencing techniques according to methods well known in the art.
  • nucleotide sequences of GS2, GS3A or GS3B promoters described herein (FIGS. 5A, 5B and 5C, respectively; SEQ. ID. NOS. 1, 2 and 3, respectively), portions thereof or nucleotide sequences homologous thereto may be used to screen genomic libraries to identify genomic clones containing homologous promoter elements using the standard techniques described supra.
  • the plasmids described in FIGS. 6, or the fragments described in FIGS. 8 and 11 could be used to such ends.
  • oligonucleotides derived from the GS2, GS3A and GS3B promoter sequences described herein could be used as primers in PCR (polymerase chain reactions) to generate GS promoter sequences from any species.
  • PCR polymerase chain reactions
  • PCR techniques see for example, Gelfand, 1989, PCR Technology. Principles and Applications for DNA Amplification, Ed., H.A. Erlich, Stockton Press, N.Y., and Current Protocols in Molecular Biology, "Vol. 2, Ch. 15, Eds. Ausubel et al., John Wiley & Sons, 1988.
  • homologous glutamine synthetase promoters in pea or in other species of plant, bacteria, or other organism may be identified.
  • Figure 5 sets forth the nucleotide sequences of the GS2 (FIG. 5A; SEQ. ID. NO. 1), GS3A (FIG. 5B; SEQ. ID.
  • GS2 directs transgene expression predominantly within photosynthetically active cells, the palisade and spongy parenchymal cells of the leaf blade, in collenchymal and chlorenchymal cells of the stem and in photosynthetic cotyledons.
  • the GS3 promoters confer vasculature-specific expression in leaves, stems and roots of mature transgenic plants, and in the cotyledons and roots of developing seedlings.
  • a short DNA element indicated in FIG. 5B from nucleotide residue number -132 to number +107 is functional when engineered into transgenic plants, and is qualitatively equivalent to the full-length GS3A promoter in its expression.
  • This DNA element comprises three portions: (a) the GS3A promoter element (FIG. 5B, nucleotide residue numbers -132 to -1; SEQ. ID. NO.
  • DNA fragments a201 (FIG. 5B, nucleotide numbers -129 to -97; SEQ. ID. NO. 2, nucleotide numbers 1704 to 1832), a202 (FIG. 5B, nucleotide numbers -129 to -106; SEQ. ID. NO. 2, nucleotide numbers 1704 to 1727) and a206 (FIG. 5B, nucleotide numbers -122 to -106; SEQ. ID. NO. 2, nucleotide numbers 1711 to 1727) contained within the -132 GS3A
  • promoter element (shown in FIG. 11A) bind to a proteinaceous factor, GS3A-F1, found in whole-cell extracts of pea, and nuclear extracts of pea and tobacco (see Section 7.2.3., infra) .
  • Nuclear and whole cell plant extracts were analyzed by DNA mobility-shift techniques to identify this novel protein which bound to a 17 bp DNA element contained within the -132 GS3A promoter element (FIG. 5B from nucleotide residue number -122 to -106; SEQ. ID. NO. 2 nucleotide numbers 1711 to 1727), having the following sequence:
  • the present invention provides for recombinant DNA constructs which contain nucleotide sequences substantially as depicted in FIGS. 5A, 5B, or 5C (SEQ. ID. NOS. 1, 2 or 3, respectively), functional portions thereof, and nucleotide sequences homologous thereto.
  • Functional portions of the glutamine synthetase promoters described herein refers to regions of the nucleic acid sequence which are capable of promoting transcription under a specific set of conditions, in a particular cell type, or otherwise.
  • Such functional portions include but are not limited to the -132 bp element of the GS3A promoter (supra); the a201, a202 and a206 sequences contained within the -132 GS3A promoter element (supra); and fragments which similarly display functional activity for GS2 or GS3B.
  • Nucleotide sequences homologous to the glutamine synthetase promoters described herein refers to nucleic acid sequences which are capable of hybridizing to the nucleic acid sequences depicted in FIG. 5 (SEQ. ID. NOS. 1, 2 or 3) in standard hybridization assays or are homologous by sequence analysis (containing a span of 10 or more nucleotides in which at least 50 percent of the nucleotides are identical to the sequences presented
  • homologous nucleotide sequences refer to
  • nucleotide sequences including, but not limited to,
  • glutamine synthetase promoter elements in diverse plant species as well as genetically engineered derivatives of the promoter elements described herein. According to the latter embodiment, it may be found that altering the sequence of the promoter element may result in a change in promoter activity, such as an increase or decrease in promoter strength or a different pattern of cell or organ-specific expression.
  • Such engineered promoter elements may be used, according to the invention, to design optimal gene fusion systems for a variety of applications.
  • the glutamine synthetase promoter elements of the invention may be used to direct the expression of glutamine synthetase or any other protein, referred to as a
  • heterologous protein or as a desired protein, or the
  • RNA product including, but not limited to, an "antisense" RNA.
  • RNA product including, but not limited to, an "antisense" RNA.
  • recombinant constructs containing a glutamine synthetase promoter element as defined in Sections 5.1 and 5.2 supra and a nucleic acid sequence encoding a desired protein are within the scope of the present invention.
  • Such constructs may include the entire GS promoter sequence, or functional portions as described in Section 5.2, ligated to the coding sequence of interest, and may or may not include sequences that encode amino acids of the glutamine synthetase structural gene.
  • constructs should be designed so that the nucleic acid encoding the desired protein is in phase with contiguous sequences of GS such that translation will result in an amino acid sequence which correlates with the amino acid sequence of the native form of the desired protein.
  • nucleotide sequences may include but are not limited to, sequences encoding a ribosome binding site
  • sequences encoding 5 ' untranslated leader sequences of mRNA species including but not limited to the 5' non-translated leader of GS3A (see FIG. 5B, nucleotide residue numbers 188; SEQ. ID. NO. 2 nucleotide number 1834 to 1920) which may confer or enhance phloem-specific expression; an intron; a 3' non-translated sequence, such as a polyadenylation signal; sequences encoding an initiation codon or a signal peptide (which facilitates secretion of the desired
  • the recombinant construct of the invention may additionally contain the left and right T-DNA border sequences.
  • the invention may include a selectable marker for propagation of the constructs.
  • the construct may comprise a gene for
  • Suitable vectors for propagating the construct would include plasmids, cosmids, and viruses, to name but a few.
  • elements described herein may be used to transform cells in culture or to engineer transgenic plants, so that expression of the gene of interest, or transgene is driven by the GS promoter element.
  • the Agrobacterium tumefaciens gene transfer system may be used to introduce the recombinant constructs of the invention into plants; generally, this system may be utilized to transfer DNA into dicotyledonous plants (Bevan et al., 1982, Ann. Rev. Genet. 16: 357-384; Rogers et al.,
  • vectors such as, but not limited to, binary Agrobacterium vectors for plant transformation may be utilized, such as, for example, the vector described by Bevan (1984, Nucl. Acids Res. 12:8711- 8721).
  • Xanthi may be transformed by a leaf inoculation procedure such as that described by Horsch et al. (1985, Science 227:1229-1231).
  • Additional methods for introducing DNA into plants may also be utilized, particularly if the recombinant construct is to be used to create a transgenic monocotyledonous plant. Such methods would include, but are not limited to
  • the second construct may be introduced separately or in tandem with the construct which comprises the glutamine synthetase promoter and the sequence encoding the desired gene product. If not constructed in tandem, the second construct may also comprise a glutamine synthetase promoter, such that
  • selectable marker or reporter gene function may serve as an indicator of promoter activity and thereby provide evidence that the gene encoding the desired gene product is actively transcribed. This may be useful when a desired protein may have activity which is difficult to identify (e.g. the desired protein influences crop yield).
  • Selectable markers would include genes which engender antibiotic resistance (for example, kanamycin resistance) or which encode a reporter gene, including but not limited to the gene for beta-glucuronidase (Jefferson, 1987, Plant Mol. Bio. Rep. 5:387-405), neomycin phosphotransferase (NPT II), and luciferase (Ow et al., 1986, Science 234:856-859) to name but a few. Detection of reporter gene expression may then be performed using methods known in the art.
  • transformants may be tested for the presence of recombinant construct by methods which would identify foreign DNA sequences, such as the Southern blot procedure. Transcription of recombinant constructs could be detected by isolating RNA from the transformant and
  • translation of the desired protein could be detected by protein gel electrophoresis, Western blot techniques, immunoprecipitation or enzyme-linked
  • the expression of the recombinant constructs of the invention may be detected in specific plant organs or tissues by determining the presence of RNA, protein, selectable marker, or reporter gene which may serve as an indicator of transcription resulting from recombinant glutamine synthetase promoter activity.
  • the GS2 promoter or GS2 homologous sequences may be detectably active in tissues such as photosynthetically active cells, including the palisade and spongy parenchymal cells of the leaf blade, in collenchymal and chlorenchymal cells of the stem, in photosynthetic cotyledons, and, at low levels, in root tips.
  • Light-enhanced promoter activity may be
  • tissue specific and light-enhanced activity of the GS2 promoter and its equivalents may be detected by the expression of the reporter gene beta-glucuronidase (Jefferson, 1987, Plant Mol. Biol. Rep. 5:387-405' see Section 6, infra).
  • the GS3A or GS3B promoters or homologous sequences may be detectably active in vascular tissues such as leaves, stems, and roots of the mature plant, and in the cotyledons and roots of developing seedlings.
  • tissue specific activity of the GS3 promoters and their equivalents may be detected by the expression of the reporter gene beta-glucuronidase (Jefferson, 1987, Plant Mol. Biol. Rep. 5:387-405; see Section 6, infra).
  • the present invention may be utilized to direct the expression of glutamine synthetase or heterologous proteins using novel plant organ specific promoter elements.
  • sequences homologous thereto, may be used to direct the expression of glutamine synthetase or heterologous gene products via recombinant nucleic acid- constructs.
  • the novel promoter elements may be used to direct the expression of glutamine synthetase.
  • Such embodiments may be useful in the engineering of plants which are genetically deficient in endogenous synthesis of glutamine synthetase or which may benefit from over production of glutamine synthetase, and may be used to introduce an isoenzyme of glutamine
  • synthetase into a cellular compartment normally occupied by an alternate isoenzyme may be used to alter expression patterns of glutamine synthetase. Manipulation of glutamine synthetase production may be advantageously used to confer herbicide resistance (see infra).
  • tissue specific and light enhanced expression of desired proteins or gene products e.g., antisense RNA
  • the GS2 promoter is selectively active in photosynthetic tissues.
  • the tissue selectivity of the GS2-like promoters may be utilized to express desired proteins or gene products in photosynthetic tissues.
  • the gene products may impact on the physiology of the plant (i.e., alter the size, growth rate, or density of
  • photosynthetic tissues may introduce a molecule which does not naturally occur in the tissue, such as an insect repellant or fungus-retardant agent.
  • an insect repellant or fungus-retardant agent such as an insect repellant or fungus-retardant agent.
  • a gene product e.g. a growth hormone expressed under the control of a GS2 promoter
  • homologous equivalents may be used to provide phloem
  • Phloem specific expression of desired gene products may be used, for example, to alter plant metabolism; since plant nutrients (carbon and nitrogen-containing compounds) are transmitted via the phloem, expression of foreign genes specifically within the phloem could be used to increase the efficiency of nutrient uptake.
  • phloem-specific expression could be utilized in the mass production of foreign proteins (including, for example, lymphokines or antibody molecules) which could be recovered from the phloem exudate by "bleeding".
  • GS2 and GS3 promoter elements may be.useful in imparting resistance to viral diseases to transgenic plants. Although viral infection in plants is not completely
  • viruses move through plants either by short distance cell to cell spread (through plasmodesmata) or by dissemination over longer distances via the plant vascular system. It has been suggested that if a virus has a specific relationship to a plant tissue, it is most commonly associated with phloem tissue; both phloem- specific as well as nonrestricted viruses have been
  • the GS2 and/or GS3 promoter elements may be used to express viral coat protein or the corresponding antisense mRNA in viral target tissues. Since viral spread appears to occur, at least in part, via the phloem, in a preferred embodiment a GS3 promoter element may be used to direct phloem-specific expression of a viral coat protein or its corresponding mRNA.
  • non-viral pathogens including
  • MLO's mycoplasma-like organisms
  • GS3 phloem specific promoter may be used to express protein or nucleic acid which negatively affects MLO expression.
  • GS2 and GS3 promoter elements may be used to develop plants which are resistant to herbicides. Like viruses, many herbicides are transported through plants via phloem tissue.
  • glyphosate N-[phosphonomethyl]glycine
  • EPP 5-enolpyruvylshikimate-3-phosphate
  • chloroplasts via a transit peptide appeared to inhibit glyphosate toxicity (Shah et al:, 1986, Science 233:478-481; Steinrucken and Amrhein, 1980, Biochem. Biophys. Res.
  • Phosphinothricin a herbicide derived from a
  • Streptomyces tripeptide antibiotic is structurally similar to glutamine and glutamate, and is a competitive inhibitor of glutamine synthetase (La Rossa and Falco, 1984, Trends in Biotechnology 2:158-161). Inhibition of phosphinothricin causes rapid accumulation of ammonia which is toxic to the plant (Tachibana et al., 1986, J. Pest. Sci. 11:33-37). A mutant of alfalfa tissue which overproduces glutamine synthetase has been observed to be resistant to the effects of the herbicide (Donn et al., 1984, J. Mol. Appl. Genet. 2:621-635).
  • phosphinothricin acetyl transferase a gene that encodes the detoxifying enzyme phosphinothricin acetyl transferase has been cloned; when expressed in calli, under the control of the CamV 35S promoter, the calli are resistant to the herbicide.
  • Sulfonylurea herbicides inhibit the activity of acetolactate synthase (ALS), a nuclear-encoded chloroplast localized enzyme (Chaleff and Ray, 1984, Science 223:1148-1151; Jones et al., 1985, Plant Physiol. 77:S293).
  • ALS acetolactate synthase
  • a nuclear-encoded chloroplast localized enzyme Chaleff and Ray, 1984, Science 223:1148-1151; Jones et al., 1985, Plant Physiol. 77:S293
  • the GS2 and/or GS3 promoters may be used to achieve herbicide resistance in the herbicide target tissues.
  • GS3 promoters may be used to achieve glutamine synthetase overproduction or the expression of inhibitory substrate or detoxifying enzyme in the phloem, the avenue of transport for most herbicides.
  • G2S promoters may be used to direct the expression of glutamine synthetase, inhibitory substrate or detoxifying enzyme in photosynthetic tissue; in specific embodiments, the glutamine synthetase, inhibitory substrate or detoxifying enzyme may be targeted to the chloroplasts via a transit peptide when herbicides are toxic to a chloroplast enzyme.
  • promoters of the invention focuses anti-herbicide activity to the tissue compartment most affected by herbicide instead of altering the physiology of the entire plant.
  • overproduction of glutamine synthetase throughout a plant may result in aberrancies of nitrogen metabolism, whereas overproduction in one tissue compartment would not.
  • GS (GS3A cy ) corresponds to the GS341 cDNA (Tingey et al.,
  • GS2ct A 1.5 kb EcoRI-Hindi fragment of the promoter region of the pea nuclear gene for chloroplast GS2 (GS2ct) was inserted into the polylinker of pBI101.2 (Jefferson, 1987, plant Mol. Bio. Rep. 5:387-405) (Clontech, Palo Alto, CA) to create the plasmid, pGS2ct-GUS (Fig. 1A).
  • pGSct-GUS contains approximately
  • GS3A cy -GUS fusion was constructed by inserting a 1.01 kb DNA fragment encompassing nucleotide position -903 to a BglII site at position +107 of the GS3A cy gene ,into the BamHI site upstream of the GUS gene in pBI101 (Jefferson, 1987, Plant Mol. Bio. Rep. 5:387-405)- Tne GS3A cy -GUS fusion gene was released from the plasmid as an Xbal-EcoRI fragment which was subsequently cloned into pMON505 (Horsch and Klee, 1986, Proc. Natl. Acad. Sci. USA.
  • pGS3A cy -GUS contains 88 nt of the 5' untranslated leader of GS3A mRNA and encodes six amino acids of the cytosolic GS protein (Tingey et al., 1988, J. Bio. Chem. 263:9651-9657).
  • Regenerated shoots were selected for growth on medium containing kanamycin (200 ⁇ g/ml).
  • transformants were maintained in sterile culture and were also grown to maturity in soil. F1 seeds were sterilized in 10% sodium hypochlorite and germinated on MS medium
  • Transgenic plants containing the GS2 ct -GUS fusion gene were germinated and grown in soil in continuous white light for 4 weeks. The plants were transferred to black Lucite boxes within a dark environmental chamber for 4 days.
  • RNA was extracted from leaves of dark-adapted and light-grown transgenic tobacco plants using guanidine thiocyanate as a protein denaturant (Chirgwin et al., 1979, Biochem. 12:5294-5304).
  • the DNA vector used (pJE1005) contained a 1.5 kb EcoRI-HincII fragment of the nuclear gene for chloroplast GS2 (GS2 ct ) in the plasmid pTZ18U (US
  • RNA polymerase (Melton, 1984, Nucleic Acid Res. 12:7035-7056). 50 ⁇ g of total RNA from transgenic tobacco plants was hybridized to an excess of the antisense RNA probe overnight in 80% formamide, 60 mM Pipes pH 6.4, 400 mM NaCl and 1 mM
  • RNAse T2 digestions were performed in a volume of 390 ⁇ l containing 50 mM NaOAc pH 5.0, 100 mM NaCl, 2 mM EDTA, and 60 units/ml of RNAse T2 (Bethesda Research Labs.) (Costa et al., 1989, EMBO J. 8:23-29). Digestion products were separated on an 8% acrylamide/7M urea gel and exposed to X-Ray film at -80°C.
  • Genomic clones encoding chloroplast or cytosolic GS of pea were isolated by hybridization to the corresponding cDNAs, pGS185 (Tingey et al., 1988, J. Bio. Chem. 263:9651- 9657) and pGS341 (Tingey et al., 1988, J. Bio. Chem.
  • the genomic clone pGS2ct corresponds to the single nuclear gene for chloroplast GS2
  • genomic clone pGS3A cy corresponds to a gene for cytosolic GS
  • GS341 which encodes the predominant mRNA for cytosolic GS in a number of organs examined.
  • Promoter elements from the gene for chloroplast GS2 and cytosolic GS3A were subcloned in translational fusions to the GUS reporter gene of
  • GUS enzyme activity was measured in soluble protein extracts of leaves of 19 individual transgenic plants by a fluorimetric assay (Jefferson, 1987, Plant Mol. Bio. Rep.
  • Chloroplast GS2 ct -GUS Transformants Cytosolic GS3A cy -GUS Transformants pGS2 ct -GUS-1 13,070 pGS3A cy -GUS-1 2,183 pGS2 ct -GUS-2 22,374 pGS3A cy -GUS-2 9,429 pGS2 ct -GUS-3 53,155 pGS3A cy -GUS-3 1,940 pGS2 ct -GUS-4 67,300 pGS3A cy -GUS-4 372 pGS2 ct -GUS-5 60,373 pGS3A cy -GUS-5 648 pGS2 ct -GUS-6 32,918 pGS3A cy -GUS-6 2,453 pGS2 ct -GUS-7 43,084 pGS3A cy -GUS-7 1,740
  • In situ GUS assays were performed on sections of leaves, stems, and roots of mature transgenic tobacco plants (Fig. 2) and on whole tobacco seedlings (Fig. 3). These assays revealed that pGS2 ct -GUS or pGS3A cy -GUS confer non-overlapping patterns of cell- and organ-specific expression on the GUS reporter gene in transgenic plants.
  • transgenic plants reveals that the promoter for chloroplast GS2 directs high-level GUS expression in leaves,
  • pGS2ct-GUS is expressed at low levels in root tips where GS in plasmids functions in ammonia assimilation from the soil (Miflin, 1974, Plant Physiol. 54:550-555).
  • GUS occurs exclusively in the vasculature, in a punctate pattern indicative of phloem-specific expression (Fig. 2E and 2F). In roots, the triarc staining pattern observed for pGS3 cy -GUS is also indicative of phloem-specific expression
  • GUS enzyme activity was detected in situ in whole mounts of germinating tobacco seedlings (Benfey et al., 1989, EMBO J.
  • GUS staining is seen throughout the cotyledons, which are photosynthetic in tobacco (Avery, 1932, Am. J. Bot. 20:309- 327) (Fig. 3A). In pea cotyledons, which are non-photosynthetic (Lovell (1977) in The Physiology of the
  • chloroplast GS2 there is low level expression of the mRNA for chloroplast GS2. Therefore, expression of chloroplast GS2 correlates with photosynthetic capacity rather than strict organ-type. In these same pGS2ct-GUS seedlings, GUS activity is not detected in the hypocotyl
  • pGS3A cy -GUS constructs are expressed exclusively in vasculature of developing transgenic
  • FIG. 3B This vasculature-specific staining pattern is most intense in the cotyledons and is also evident in the hypocotyl and root (Fig. 3B).
  • the emerging leaves of pGS3A cy -GUS transgenic seedlings do not contain detectable levels of GUS (Fig. 3B).
  • the absence of GUS expression in these young leaves is consistent with the apparent lack of vascularization of leaves in these young seedlings (Pato et al., 1970, Protoplasma 71:313-334). As the seedlings mature, and the leaves become vascularized,
  • GUS activity is detected in the vasculature of pGS3A cy -GUS transgenic seedlings.
  • Control F1 seedlings derived from plants transformed with a "promoter-less" GUS construct
  • RNA corresponding to the chloroplast GS2-GUS chimeric RNA drops to undetectable levels when the mature light-grown plants are placed in the dark for 4 days (Fig. 4, lanes 1 and 3).
  • the GS2ct-GUS mRNA accumulates approximately 8-fold (Fig. 4, lanes 2 and 4).
  • the white-light induction of the steady-state levels of GS2ct-GUS mRNA in transgenic plants demonstrates that cis-acting elements involved in the light regulation of the pea GS2ct gene are contained within a 1.5 kb promoter fragment.
  • cytosolic GS3A confers vasculature-specific GUS expression in leaves, stems, and roots of the mature plant, and in the cotyledons and roots of developing seedlings.
  • chloroplast GS2 functions in the reassimilation of photorespiratory ammonia (Wallsgrove, et al., 1987, Plant Physiol. 83:155-158;
  • chloroplast GS2 in the reassimilation of photorespiratory ammonia.
  • the high-level expression of the gene for cytosolic GS3A in the vasculature is particularly intense in the cotyledons of germinating seedlings where glutamine serves to transport nitrogen from seed storage reserves to the developing plant.
  • promoters for two cytosolic GS genes of Phaseolus vulgaris can direct expression in transgenic Lotus corniculatus nodules, and that one of these promoters is active in vascular and cortical cells of the nodule (Forde et. al., 1989, Plant Cell 1:391-401).
  • chloroplast GS2 ct -GUS transgene contained, on average, 17 times more GUS activity than plants containing the GS3A cy - GUS construct.
  • the expression of each of the GS-GUS constructs is confined to distinct leaf cell types which comprise different fractions of the total leaf cell population, the relative amount of GUS activity in whole leaf extracts cannot be regarded as a measure of absolute promoter strength.
  • GS2 ct -GUS mRNA reveals that the promoter for GS2 ct contains a cis-acting DNA element involved in light regulation.
  • plastid GS2 is also present in non-photosynthetic cell types such as etiolated leaves (Hirel, 1982, Planta 155:17-23) and roots
  • the regulation of expression of the GS2ct gene is likely to differ from that of other light-regulated genes which function solely in photosynthesis (e.g. ribulose 1,5 bis-phosphate carboxylase, chlorophyll a/b binding protein).
  • GS isoforms in plant nitrogen metabolism the transgenic studies presented here describe plant promoters which may be used to direct cell-specific expression of foreign genes in plants.
  • a promoter which confers specific expression of foreign genes in phloem cells has potential application in generating resistance to viral pathogens transmitted within the phloem (Schneider, 1965, 11:163-221).
  • glutamine synthetase is the target of several herbicides (Kishore, et al., 1988, 57:627-663), the
  • DNA mobility-shift analysis identified a protein present in nuclear and whole cell plant extracts which bound to a 17 bp DNA element contained within the minimal -132 promoter required for expression (FIG. 5B, nucleotide number -122 to -106; SEQ. ID. NO. 2, nucleotide number 1711 to 1727).
  • the DNA sequence of the promoter of the GS3A gene, the expression patterns the full-length promoter, and a series of 5' deletions in both transgenic tobacco and transgenic alfalfa were analyzed.
  • This promoter fragment was subsequently used to identify a novel DNA-binding protein present in nuclear and whole-cell plant extracts.
  • a clone carrying a 5.76 kb insert was isolated from a genomic library of Pisum sativum cv. 'Sparkle' constructed in 'lambda dash' (Stratagene) using the GS3A (a.k.a. GS341) cDNA as a hybridization probe (Tingey et al., 1987, EMBO J. 6: 1-9). Standard procedures were used for library
  • the 5.76 kb insert was transferred to pEMBL18 for sequencing using the dideoxy chain-termination (Biggin et al., 1983, Proc. Natl. Acad. Sci. USA 80: 3963-3965; Murphy and Kavanagh, 1988, Nuc.
  • the transcriptional start site of the GS3A promoter was mapped by 5' SI analysis.
  • a uniformly labelled DNA probe was prepared using the oligonucleotide EW1 (extending from +85 to +104) as a primer on a GS3A genomic clone template corresponding to the deletion A16 cloned in
  • This DNA probe was hybridized to total RNA from leaves, roots, 21 day old nodules and cotyledons of 5 day old seedlings, all from pea. Following incubation with SI nuclease, the products were separated on a 5% denaturing polyacrylamide sequencing gel. Dideoxy sequencing reactions of the DNA probe also primed by EW1 were run alongside the SI nuclease digestion products.
  • deletions were excised from pTZ by SphI-EcoRI digestion and transferred to pBinl9 (Bevan, 1984, Nuc. Acids Res. 12: 8711-8721) between the Hindlll and EcoRI sites using a HindIII-SphI adaptor-linker.
  • Fluorometric GUS enzyme assays were done as previously described (Jefferson et al., 1987, Plant Mol. Biol. Rep. 5: 387-405). Five ⁇ g of protein were incubated with 4-methylumbelliferyl glucuronide (MUG) solution for 15 minutes after which 2.5 ml of 0.2 M sodium carbonate were added. Fluorescence was measured with a Perkin Elmer LS5
  • Fragments for DNA mobility-shift analysis were synthesized as oligonu ⁇ leotides, and complementary
  • oligonucleotides annealed and cloned into pTZ19U derived vectors. Fragments were excised from the vector, purified by polyacrylamide gel electrophoresis, and then end-labelled with 32 P-dATP, 32 P-dCTP, 32 P-dGTP, 32 P-TTP using the Klenow enzyme. DNA-protein binding was done for 30 minutes at room temperature in 20 mM Hepes-KOH pH 7.5, 40 mM KCl, 1 mM EDTA, 10% glycerol (Katagiri et al., 1989 Nature 340: 727-730). Five ⁇ g sonicated polydldC (Pharmacia) was used as non- specific competitor DNA. Whole-cell and nuclear extracts were prepared as previously described (Green et al., 1987, EMBO J. 6: 2543-2549; Green et al., 1989, Plant Molecular Biology Manual Bll, pp. 1-22.
  • FIG. 5B shows the sequence of the GS3A promoter extending from -1832 relative to the start of transcription to +107 (SEQ. ID. NO. 2 , numbers 1 to
  • S1 analysis located the start of transcription to both of two adenosines underlined in FIG. 5B. For the purposes of consistency we notate the second A as +1 (SEQ. ID. NO. 2 , nucleotide number 1833).
  • the transcriptional start site was mapped using RNA from several organs to determine if transcription initiation was identical in organs as diverse as cotyledons and root nodules. The results of this analysis indicate that identical
  • a series of 5' promoter deletions of GS3A were ligated to GUS and introduced into tobacco and alfalfa by Ti-mediated DNA transfer. Deletions were made in translational fusion at +107 (SEQ. ID. NO. 2 at 1939) using the BglII site, and therefore include 19 bp of the GS coding sequence (FIG. 8). As described in Section 6, supra, a translational fusion of -903 bp (SEQ. ID. NO. 2 at 929) assayed in
  • transgenic tobacco was found to confer phloem-specific expression.
  • Our aim was to assess the expression, pattern of GS3A promoter fragments up to approximately 2000 bp driving ⁇ -glucuronidase expression, to identify which promoter elements were responsible for the phloem-specific expression pattern, and to compare this activity to the expression pattern found in the legume alfalfa, in particular in alfalfa nodules.
  • FIG. 8 A45, A22, A16, A13, A10
  • FIG. 9 Transgenic alfalfa plants were produced using four of these constructions (A28, A22, A13, and A10). All four constructs expressed GUS, and expression was again localized to the phloem cells of the leaf (FIG. 10F), stem (FIG. 10G), and root (FIG. 10C) vasculature, and additionally to root tips.
  • GS3A promoter directed GUS expression at early stages of nodule formation in the nodule primordia (FIGS. 10A and 10B), and as nodule development proceeded, GUS expression was highest in the meristem and early symbiotic zones and undetectable in the senescent zone (FIGS. 10C, 10D, 10J, 10K and 10L). GUS expression was also visible in the vascular elements around the central infection zone (FIG. 10E).
  • Control nodules formed on plants transformed with pBI101 showed no GUS expression (FIG. 101).
  • the -132 GS3A promoter deletion confers expression in phloem cells of leaves, stems, roots, cotyledons, and nodules, in root tips and also in the meristem and symbiotic zone of nodules.
  • This 132 bp promoter fragment may therefore contain a single cis-element which activates transcription in phloem,
  • DNA elements contained within the -132 GS3A promoter were used in DNA mobility-shift assay to identify DNA binding proteins in plants extracts which may play a role in the transcriptional activation of the gene. Mobility-shift assays were undertaken with radio-labelled DNA fragments spanning the -132 GS3A promoter; these fragments are shown
  • Fragment a201 which extends from -129 to -97 relative to the start of transcription (SEQ. ID. NO. 2, from nucleotide number 1704 to 1736), was found to bind a factor which was designated GS3A-F1.
  • GS3A-F1 was present in whole-cell extracts of pea, and nuclear extracts of pea and tobacco; it was sensitive to boiling and treatment with proteinase K, indicating the proteinaceous nature of GS3A- F1.
  • Fragments a202 (-129 to -106; SEQ. ID. NO. 2, 1704- 1736) and a206 (-122 to -106; SEQ. ID. NO.
  • the overlapping region of a202 and a206 is a core of 17 nucleotides which contains an imperfect inverted repeat. Fragment a206 contains an imperfect palindrome, and this was bisected by fragments a230 (-173 to -114; SEQ. ID. NO. 2, 1660 to 1719) and a239 (-113 to -54; SEQ. ID. NO. 2, 1720 to 1779), neither of which were able to bind GS3A-F1. However, when used as unlabelled competitors, both a230 and a239 were able to decrease the binding of GS3A-F1 to a201 and a202 (FIG. 11).
  • promoter is expressed in a phloem-specific fashion in both transgenic tobacco and in transgenic alfalfa.
  • the pattern and degree of promoter activity is reflective of glutamine synthesis in phloem cells and the significance of glutamine as a long-distance nitrogen transport compound; i.e., the GS3A gene is expressed at highest levels in pea organs where large amounts of nitrogen are mobilized. Quantification of GUS expression demonstrated that GS3A activity was indeed highest in root nodules of transgenic alfalfa.
  • the pattern of GUS expression conferred by the GS3A promoter in transgenic alfalfa differs from that described for GS promoters from Phaseolus vulgaris and soybean GS when introduced into transgenic Lotus corniculatus.
  • Expression of the Phaseolus vulgaris gln- ⁇ gene in Lotus corniculatus was restricted to infected cells of the nodule.
  • Alfalfa was selected as the host legume for the transgenic studies described infra as it possesses determinate nodules similar to those of pea, and both pea and alfalfa are
  • nodules e.g. pea and alfalfa.
  • GS3A promoter deletion analysis we were able to define the region of the GS3A promoter involved in its phloem-specific, cell-specific and developmentally-regulated expression.
  • a short DNA element of GS3A (position -132 to +107 indicated in FIG. 5B; SEQ. ID. NO. 2 nucleotide numbers 1701 to 1939) was functional in both tobacco and alfalfa and was qualitatively equivalent to the full-length promoter in its expression.
  • DNA fragments a201, a202 and a206 contained within the -132 GS3A promoter element (shown in FIG. 11A) were found to bind a proteinaceous factor, GS3A-F1, found in whole-cell extracts of pea, and nuclear extracts of pea and tobacco.
  • transcription factors involved in promoting gene expression are not confined to nodules. This is consistent with our observation that the same transcription initiation site is utilized in cotyledons and nodules. Furthermore, it is compatible with the finding that at least one nuclear protein factor which interacts with the GS3A promoter
  • G3A-F1 is present in both pea and tobacco extracts.
  • GS gene expression is mediated by plant hormones in both nodules and cotyledons. It is curious that the 17 bp element of the GS3A promoter contained within a206 (indicated in FIG. 5B; SEQ. ID. NO. 2 from 1711 to 1727) which binds the protein factor GS3A-F1 is itself palindromic and similar to the palindromic mammalian steroid response element (Evans, 1988, Science 240: 889- 895). This homology is intriguing because GS expression in animals has been shown to be steroid-induced in at least one mammalian cell line (Miller et al., 1978, Proc. Natl. Acad. Sci.
  • the factor GS3A-F1 is present in both pea and tobacco extracts and this is consistent with the activity of the GS3A promoter in both these species.
  • MOLECULE TYPE DNA (genomic)
  • CAATAGCCAA CAAACTTGTT TTCTTGCCCA CCACCAACCC TTATTTTACA CAACTCTCTC 960
  • MOLECULE TYPE DNA (genomic)
  • ACATACTTAA AAAATATTCT TTTTCATACA TATTAATTAA ATGAAGTATC CTACCAACCA 780

Abstract

The present invention relates to novel plant organ-specific transcriptional promoter nucleic acid sequences, which regulate the expression of glutamine synthetase isoenzymes. Specifically, promoter sequences were isolated from the nuclear gene for chloroplast GS2 glutamine synthetase and from two nuclear genes for cytosolic GS3 glutamine synthetase in the pea plant, Pisum sativum. Accordingly, the present invention provides for the nucleic acid sequences of the GS2, GS3A and GS3B promoter sequences as well as functional portions thereof. The invention further provides for promoters homologous to GS2, GS3A and GS3B, or any portion thereof as well as gene fusions and transgenic plants in which genes that encode heterologous proteins are controlled by the promoter sequences of the invention.

Description

NOVEL ORGAN-SPECIFIC PLANT PROMOTER SEQUENCES
1. INTRODUCTION
The present invention relates to novel plant organ- and cell- type specific transcriptional promoter nucleotide sequences which regulate the expression of genes encoding glutamine synthetase isoenzymes. In particular, one
promoter sequence which responds to light and two promoter sequences which are selectively active in plant vascular elements have been cloned and characterized. The promoter sequences of the invention may be used to control the expression of glutamine synthetase as well as genes encoding heterologous proteins, and may advantageously be used to render plants resistant to herbicides or viral or pathogen infection.
2. BACKGROUND OF THE INVENTION
2.1. THE GLUTAMINE SYNTHETASE SYSTEM
In higher plants, many steps in nitrogen metabolism occur in multiple subcellular compartments. For example, isoenzymes for many amino acid biosynthetic enzymes are located in the cytosol, as well as in the mitochondria or chloroplasts. The significance of this multiplicity and compartmentalization of plant isoenzymes has yet to be fully understood. The relative function of many amino acid biosynthetic isoenzymes has been difficult to assess due to inadequate fractionation of organelle and cytoplasm
components, overlapping activity profiles, and immunological cross-reactivity (Miflin and Lea, 1982, in "Nucleic Acid and Proteins in Plants I: Structure, Biochemistry and Physiology of Proteins," eds. Boulter, D. & Parthier, B., Springer-Verlag, Berlin Heidelberg New York, pp. 5-64).
Consequently, it is unclear whether these isoenzymes carry out redundant or distinct roles in plant metabolism. The best studied example of a plant amino acid
biosynthetic enzyme shown to occur as multiple isoforms is glutamine synthetase (GS) (EC 6.3.1.2) (McNally et al., 1983, Plant Physiol. 72:22-25). Early biochemical data revealed that GS functions in the assimilation of ammonia generated by numerous plant processes which include seed germination (Kern and Chrispeels, 1978, Plant Physiol.
62:642-647; Winter et al., 1982, Plant Physiol. 69:41-47), photorespiration (Wallsgrove et al., 1983, Plant Cell
Environ. 6: 301-309; Wallsgrove et al., 1987, Plant Physiol. 83:155-158), nitrite reduction (Miflin, 1974, Plant Physiol. 54: 550-555), nitrogen-fixation in root nodules (Robertson et al., 1975, Aust. J. Plant Physiol. 2:265-272; Lara et al., 1983, Plants 157: 254-258), and primary ammonia
assimilation from the soil (Hirel and Gadal, 1980, Plant Physiol. 661: 619-623). An analysis of the GS genes in several species has revealed a strong correlation of
individual GS gene expression with specific aspects of plant development (Tingey et al., 1987, EMBO J. 6:1-9; Tingey et al., 1988, J. Bio. Chem. 263:9651-9657; Hirel et al., 1987, EMBO J. 6:1167-1171; Forde et al., 1989, Plant Cell 1:391-401; Gebhardt et al., 1986, EMBO J. 5: 1429-1435; Edwards and Coruzzi, 1989., Plant Cell 1:241-248). Recent sequence analysis of GS cDNAs from Pisum sativum and Phaseolus vulgaris has shown that chloroplast and cytosolic GS are encoded by separate but similar nuclear genes (Tingey et al., 1987, EMBO J. 6:1-9; Tingey et al., 1988, J. Bio. Chem. 263:9651-9657; Cullimore et al., 1984, J. Mol. Appl. Genet. 2:589-599).
In pea, the single nuclear gene for chloroplast GS2 is expressed predominantly in leaves in a light-dependent fashion (Tingey et al., 1988, J. Bio. Chem. 263:9651-9657; Edwards and Coruzzi, 1989, Plant Cell 1:241-248). The role of chloroplast GS2 in the reassimilation of photorespiratory ammonia is supported by the analysis of mutants in barley (Wallsgrove et al., 1987, Plant Physiol. 83:155-158), and is substantiated by gene expression studies in pea (Edwards and Coruzzi, 1989, Plant Cell 1:241-248). For cytosolic GS, molecular studies have revealed the presence of a number of distinct isoforms in several plant species (Tingey et al., 1988 J. Bio. Chem. 263:9651-9657; Hirel et al., 1987, EMBO J. 6: 1167-1171; Gebhardt et al., 1986, EMBO J. 5:1429-1435; Tingey and Coruzzi, 1987, Plant Physiol. 84:366-373). In pea it has been shown that two classes of genes encode homologous but distinct cytosolic GS isoforms (Tingey, 1988, J. Bio. Chem. 263:9651-9657). One class comprises a pair of "twin" GS genes (GS3A and G3B) whose expression is
specifically induced in two developmental contexts where large amounts of ammonia are mobilized for plant growth, during germination and nitrogen fixation.
2.2. PLANT PROMOTER/ENHANCER SEQUENCES A number of plant promoter enhancer/sequences have been identified, including light-responsive promoter
sequences such as ribulose bisphosphate carboxylase (Coruzzi et al., 1984, EMBO J. 3: 1671-1680; Herrera-Estrella et al., 1984, Nature 310:115-120), the chlorophyll a/b binding protein (Cab) of the light-harvesting chlorophyll-protein complex (Apel et al., 1978, Eur. J. Biochem. 85:581-588;
Stiekema et al., 1983, Plant Physiol. 72:717-724; Thompson et al., 1983, Planta 158: 487-500; Jones et al., 1985, EMBO J. 4: 2411-2418) and the ST-LSl gene of potato (Stockhaus et al., 1989, Plant Cell 1 : 805-814). Additional plant promoter sequences include the soybean heat shock protein hsp17.5-E or hspl7.3-B promoters (Gurley et all, 1986, Mol. Cell Biol. 6:559-565); the Parasponia andersoni hemoglobin promoter (Landsmann et al., 1988, Mol. Gen. Genet. 214:68-73); the phenylalanine ammonia-lyaεe promoter, which appears to be active in specific cell types which accumulate phenylpropanoid derivatives in response to wounding and also during normal development of the xylem and flower (Bevan et al., 1989, EMBO J. 8:1899-1906); and the petunia 5- enolpyruvylshikimate-3-phosphate synthase gene promoter (Benfey and Chua, 1989, Science 244:174-181). Certain plant promoters, such as patatin, have also been shown to function in specialized organs such as tubers (Rocha-Sosa et al., 1989, EMBO J. 8:23-29).
Certain bacterial promoters have been observed to be expressed in plants, including the Rhizobium meliloti FIXD gene promoter described in U.S. Patent No. 4,782,022, issued November 1, 1988, by Puhler et al., and the nopaline
synthase promoter (Ha and An, 1989, Nucleic Acids Res.
17:215-224; An et al., 1988, Plant Physiol. 88:547-552).
Several promoter sequences, termed the rol A, B and C promoters, have been identified in Agrobacterium rhizogenes (Schmulling et al., 1989, Plant Cell 1:665-670; Sugaya et al., 1989, Plant Cell Physiol. 30:649-654). The rol C promoter described by Sugaya et al. (supra), located on the bacterial Ri plasmid, has been observed to be expressed in phloem cells.
Viral genes which are expressed in plants include the cauliflower mosaic virus (CaMV) 35S promoter (Odell et all, 1985, Nature 313:810-812; Jensen et al., 1986, Nature
321:669-674; Jefferson et al., 1987, EMBO J. 6 : 3901-3907; and Sanders et al., 1987, Nuc. Acids Res. 14:1543-1558).
Within the CaMV 35S promoter, expression conferred by domain A (-90 to +8) was found to be particularly strong in root tissue, whereas expression conferred by domain B (-343 to -90) appeared to be strongest in the cotyledons of seeds and seedlings and in the vascular tissue of the hypocotyl
(Benfey et al., 1989 EMBO J. 8:2195-2202). 3. SUMMARY OF THE INVENTION
The present invention relates to novel plant organ-specific transcriptional promoter nucleotide sequences which regulate the expression of genes encoding glutamine
synthetase isoenzymes. Specifically, promoter sequences were isolated from the nuclear gene for chloroplast GS2 glutamine synthetase and from two nuclear genes for
cytosolic GS3 glutamine synthetase in the pea plant, Pisum sativum. Accordingly, the present invention provides for the nucleic acid sequences of the GS2, GS3A and GS3B
promoter sequences as well as functional portions thereof.
The invention further provides for promoters
homologous to GS2, GS3A and GS3B, gene fusions comprising the novel glutamine synthetase promoters, and transgenic plants which comprise the promoters of the invention.
Experiments which tested the activity of the GS2, GS3A and GS3B promoter sequences revealed that the GS2 promoter was inducible by light and directed high levels of
transcription in photosynthetic cells of leaves. In
addition, the GS2 promoter directs expression in
nonphotosynthetic cells of the root tip. GS3A was found to be selectively active in phloem; therefore, GS3A represents the first plant-derived, phloem-specific promoter element. In various embodiments of the invention, the GS2, GS3A, and GS3B promoter sequences may be used to control the
expression of glutamine synthetase as well as heterologous proteins in a tissue specific and/or light-inducible manner. The resulting tissue-specific expression of a desired gene product presents a wide range of potential applications for the promoter sequences of the invention, including, but not limited to, the manipulation of nutritional requirements and the induction of resistance to herbicides or pathogens. 3.1. ABBREVIATIONS
transgenic plant: a plant which has incorporated a foreign gene into its genome
transgene = transgenic sequence: a foreign gene which has been incorporated into a transgenic plant
4. DESCRIPTION OF THE FIGURES
Figure 1. GS-GUS Translational Fusions. A) pGS2ct
GUS contains 1.5 kb of the gene for chloroplast GS2 in a translational fusion with the GUS gene of pBI101.2. B) pGS3Acy-GUS contains 1.01 kb of the gene for cytosolic GS3A in a translational fusion with the GUS gene of pBHOl. A 3' polyadenylation region from the nopaline synthase gene is present in both GS-GUS constructs and is denoted with diagonal stripes. The white areas represent the 5'
noncoding region of each GS gene. The solid black areas depict GS coding regions and the dotted area marks the GUS coding region.
Restriction sites: E = EcoRI, H = HincII, Bg = BglII.
Restriction sites in parenthesis indicate original sites in plant genes which were destroyed in plasmid construction.
Figure 2. Histochemical localization of GUS activity in cross sections of mature transgenic tobacco plants.
Panels A-D represent sections from pGSct-GUS transformants;
A) leaf cross section, B) leaf blade cross section, C) leaf midrib cross section, D) stem cross section. Panels E-H represent sections from pGS3Acy-GUS transformants: E) leaf cross section, F) leaf midrib cross section, G) root cross section, H) stem cross section. Abbreviations: CH-chlorenchyma, CL - collenchyma, E - epidermis, LB - leaf blade, MV - midvein, PH - phloem, PP - palisade parenchyma,
PT - pith parenchyma, R - root, SP - spongy parenchyma, T -trichome, V - vasculature, X - xylem. Figure 3. Histochemical localization of GUS activity in whole mounts of 7 day-old transgenic tobacco seedlings; A) pGS2ct-GUS transformant. B)- pGS3Acy-GUS transformant. C) control, pBHOl transformant. Abbreviations: C -cotyledon, H - hypocotyl, L - leaf, R - root, V -vasculature.
Figure 4. Ribonuclease T2 protection analysis of pGS2ct-GUS transcripts in light- vs. dark-grown transgenic tobacco. Autoradiograph of the 162 nt fragment protected from RNAse T2 digestion in hybridizations containing 50 μg of total RNA isolated from: A) and B) two separate pGS2ct
GUS transformants; C) and a control, pBHOl transformant which was dark-adapted for 4 days (lanes 1 and 3), and subsequently grown in continuous white light for 24 hrs.
(lanes 2, 4, and 5).
Figure 5. Nucleotide sequence of (A) GS2 (SEQ. ID.
NO. 1); (B) GS3A (SEQ. ID. NO. 2); and (C) GS3B (SEQ. ID.
NO. 3) promoter elements. In FIG. 5B, the sequence of the
GS3A promoter is shown from nucleotide -1832 relative to the start of transcription to the Bglll site extending to +107
(SEQ. ID. NO. 2 , numbers 1 to 1939). Putative CAAT and TATA boxes are underlined, as is the first coding sequence ATG.
The start of- transcription was mapped to the two adenosines also underlined; the second of these is notated elsewhere as
+1, and is written in lower case in the figure. Nucleotides
-122 to -106 represent fragment a206 and the smallest defined sequence to bind the protein GS3A-F1 (SEQ. ID. NO.
2, numbers 1711 to 1727).
Figure 6. Promoters for (A) GS2, (B) GS3A, and (C)
GS3B subcloned into Bluescnpt® SK+ vectors. Gene sequences are in upper case letters, vector and linker sequences are in lower case letters. Restriction sites destroyed in cloning are marked in parentheses. All restriction sites are underlined. Numbers refer to the nucleotides of GS promoter as specified in FIG. 5.
Figure 7. Identification of the transcriptional start site of the GS3A promoter. 5' SI nuclease analysis was undertaken on 10 μg of total RNA from leaves, roots, nodules and cotyledons. Oligonucleotide EW1 was used to prepare a labelled probe complementary to the GS3A mRNAs and also sequencing reactions on the non-coding strand. Lane 1: tRNA control; lane 2: leaf RNA; lane 3: root RNA; lane 4: nodule RNA; lane 5: cotyledon RNA. GATC are the sequencing
reactions transcribed to the sense strand. The sequence from either side of the start site is shown with the two major transcriptional start sites boxed.
Figure 8. Deletion analysis of the GS3A promoter.
Six promoter deletions were transferred to transgenic tobacco and alfalfa in translational fusion to GUS. The relative positions of CAAT and TATA boxes and the
transcriptional start site (X) are indicated schematically (exact positions for these can be found in FIG. 5B) . The sequence of the first 16 codons illustrate the nature of the fusion constructed. Codons 1 to 6 are derived from GS3A coding sequence, codons 7 to 11 are derived from polylinker sequence, codons 12 to 15 are derived from the GUS leader, and codon 16 is the GUS ATG.
Figure 9. Histochemical detection of GUS in
transgenic tobacco. GUS expression in tobacco seedlings. Panels A and B: cotyledons of transgenic constructions A28 and A10, which correspond to the longest and shortest deletions respectively. Panel C: A28 seedlings. Panel D: root tip of an A28 seedling. Panels E and F: 8 μm leaf sections of a mature A28 alfalfa transformant (panel E is counterstained with erythrosin) showing expression localized to phloem, v: vasculature; rh: root hairs. Figure 10. Histochemical detection of GUS in
transgenic alfalfa. Panels A to D: GUS expression in nodules of an A13 transformant at different stages of maturity (from between 2 and 5 weeks post-nodulation).
Panel E: transverse section through an A13 nodule expressing GUS. Panel F: GUS expression: in an A13 leaf. Panel G:
transverse stem section, A13 transformant. Panel H: GUS expression in A28 nodules. Panel I: nodules on the pBI101 transformed control. Panels J, K, and L: 8 μm nodule sections (counterstained with erythrosin) allowing the definition of the cell-type expression of GUS (A28
transformants). np: nodule primordium; v: vasculature; c: cortical cells; m: meristematic cells; s: symbiotic zone; es: early symbiotic zone; Is: late symbiotic zone; sn:
senescent zone; r: root.
Figure 11. A putative cis-element in the GS3A
promoter. Panel A: The GS3A promoter sequence immediately adjacent to the shortest 5' deletion (A10) extending from -132 to -94 is shown (SEQ. ID. NO. 2, numbers 1701 to 1739). The imperfect palindrome contained in this sequence is indicated by the arrows. Bars below the DNA sequence indicate the five DNA fragments spanning this region of the GS3A promoter which were used in mobility-shift assays:
a201 (-129 to -97; SEQ. ID. NO. 2, number 1704 to 1736);
a202 (-129 to -106; SEQ. ID. NO. 2, number 1704 to 1727); a206 (-122 to -106; SEQ. ID. NO. 2 number 1711 to 1727);
a230 (-173 to -114; SEQ. ID. NO. 2, number 1660 to 1719); a239 (-113 to -54; SEQ. ID. NO. 2, number 1720 to 1779).
The dashed lines on fragment a230 and a239 indicate that these fragments extend laterally beyond the sequence shown to the positions indicated above. Nuclear extracts used in these assays were prepared from mature, dark-adapted tobacco plants. Panel B: Fragement a202 (lanes 1-8), and fragment a206 (lanes 9-12) were used as probes in gel-molility assays using tobacco nuclear extracts. All lanes are from the same gel. Lane 1: free a202 probe; lane 2: probe + extract; lane 3 : probe + extract + 10-fold molar excess of unlabelled a202; lane 4: probe + extract + 50-fold molar excess of unlabelled a202; lane 5: probe + extract + 10-fold molar excess of unlabelled a230; lane 6: probe + extract + 50-fold molar excess of unlabelled a230; lane 7: probe + extract + 10-fold molar excess of unlabelled a239; lane 8: probe + extract + 50-fold molar excess of unlabelled a239. Lane 9: free a206 probe; lane 10: probe + extract; lane 11: probe + extract + 10-fold molar excess of unlabelled a206; lane 12: probe + extract + 50-fold molar excess of unlabelled a206. Lane 13: probe + extract + 10-fold molar excess of a202 competitor; lane 14: probe + extract + 50-fold molar excess of a202 competitor. Panel C: Fragment a201 was used as a probe in DNA mobility-shift assays again using tobacco nuclear extracts. All lanes are from the same gel. Lane 1: free a201 probe; lane 2: probe + extract; lane 3: probe + extract + 25-fold molar excess of a GTl-binding tetrameric competitor; lane 4: probe + extract + 125-fold molar excess of the same competitor; lane 5: probe + extract + 25-fold molar excess of a mutant tetrameric competitor which does not bind GT1; lane 6: 125-fold molar excess of the same mutant competitor. In each case approximately 1 ng of probe was used corresponding to c. 10,000 counts per minute.
5. DETAILED DESCRIPTION OF THE INVENTION The present invention relates to novel plant organ-specific transcriptional promoters which control the
expression of glutamine synthetase isoenzymes, and provides for (i) promoter elements such as GS2, GS3A and GS3B, which have nucleotide sequences substantially as depicted in FIG. 5A, 5B and 5C, respectively (SEQ. ID. NOS. 1, 2 and 3, respectively), or nucleotide sequences homologous thereto; (ii) gene fusions containing these promoter elements; (iii) methods for producing tissue-specific expression of
glutamine synthetase or heterologous proteins utilizing the novel promoters; and (iv) transgenic plants containing transgenes which include the promoter elements of the invention. The invention is based, in part, on the
discovery that the promoters for chloroplast GS2 and
cytosolic GS3 of Pisum sativum confer non-overlapping, cell-specific expression patterns to the beta-glucuronidase (GUS) reporter gene in transgenic tobacco plants (See
Section 6, infra). The promoter for chloroplast GS2 was observed to direct GUS expression within photosynthetic cell types (e.g. palisade parenchymal cells of the leaf blade, chlorenchymal cells of the midrib and stem, and in
photosynthetic cells of tobacco cotyledons) . The promoter for chloroplast GS2 appeared to retain the ability to confer light-regulated gene expression in the heterologous
transgenic tobacco system in a manner analogous to the light-regulated expression of the cognate gene for
chloroplast GS2 in pea. These expression patterns may reflect the physiological role of the chloroplast GS2 isoform in the assimilation of ammonia generated by nitrite reduction and photorespiration. In contrast, the promoter for cytosolic GS3A was found to direct expression of GUS specifically within the phloem elements in all organs of mature plants. This phloem-specific expression pattern suggests that the cytosolic GS3A isoenzyme may function to generate glutamine for intercellular nitrogen transport. In germinating seedlings, the intense expression of the
cytosolic GS3Acy-GUS transgene in the vasculature of
cotyledons suggests a role for cytosolic GS3A in the
mobilization of nitrogen from seed storage reserves. For purposes of clarity of disclosure, and not by way of limitation, the invention is described in the following subsections:
(i) Identification of promoter elements associated with glutamine synthetase genes;
(ii) Novel glutamine synthetase promoter elements; (iii) Gene fusions containing glutamine synthetase
promoter elements; and
(iv) Creation of transgenic plants containing
recombinant glutamine synthetase promoter elements;
(v) Utility of the GS promoter elements.
5.1. IDENTIFICATION OF PROMOTER ELEMENTS ASSOCIATED WITH GLUTAMINE SYNTHETASE GENES
According to the present invention, promoter elements associated with glutamine synthetase genes may be identified from any species of plant, bacteria, or virus using any method known in the art. For example, genomic DNA libraries may be screened for clones containing sequences homologous to known glutamine synthetase genes or, alternatively, glutamine synthetase promoter sequences. For example, cDNA clones corresponding to mRNA which encodes glutamine
synthetase, or oligonucleotide probes corresponding to known glutamine synthetase amino acid sequence may be used to identify homologous clones in a genomic DNA library using methods such as, for example, the method set forth in Benton and Davis (1977, Science 196:180) for bacteriophage
libraries, and Grunstein and Hogness (1975, Proc. Natl.
Acad. Sci. U.S.A. 72:3961-3965) for plasmid libraries.
Retrieved clones may then be analyzed by restriction-fragment mapping and sequencing techniques according to methods well known in the art. In another approach, nucleotide sequences of GS2, GS3A or GS3B promoters described herein (FIGS. 5A, 5B and 5C, respectively; SEQ. ID. NOS. 1, 2 and 3, respectively), portions thereof or nucleotide sequences homologous thereto may be used to screen genomic libraries to identify genomic clones containing homologous promoter elements using the standard techniques described supra. For example, the plasmids described in FIGS. 6, or the fragments described in FIGS. 8 and 11 could be used to such ends.
Alternatively, oligonucleotides derived from the GS2, GS3A and GS3B promoter sequences described herein could be used as primers in PCR (polymerase chain reactions) to generate GS promoter sequences from any species. For a review of such PCR techniques, see for example, Gelfand, 1989, PCR Technology. Principles and Applications for DNA Amplification, Ed., H.A. Erlich, Stockton Press, N.Y., and Current Protocols in Molecular Biology, "Vol. 2, Ch. 15, Eds. Ausubel et al., John Wiley & Sons, 1988.
Using any of the foregoing approaches, homologous glutamine synthetase promoters in pea or in other species of plant, bacteria, or other organism may be identified.
5.2. NOVEL GLUTAMINE SYNTHETASE PROMOTER ELEMENTS
Figure 5 sets forth the nucleotide sequences of the GS2 (FIG. 5A; SEQ. ID. NO. 1), GS3A (FIG. 5B; SEQ. ID.
NO.2), and GS3B (FIG. 5C; SEQ. ID. NO. 3) promoter elements. The activity of the GS2 promoter is induced by light. When engineered into transgenic plants, GS2 directs transgene expression predominantly within photosynthetically active cells, the palisade and spongy parenchymal cells of the leaf blade, in collenchymal and chlorenchymal cells of the stem and in photosynthetic cotyledons. In contrast, the GS3 promoters confer vasculature-specific expression in leaves, stems and roots of mature transgenic plants, and in the cotyledons and roots of developing seedlings.
By promoter deletion analysis, we defined the region of the GS3A promoter involved in its phloem-specific and developmentally-regulated expression. A short DNA element indicated in FIG. 5B from nucleotide residue number -132 to number +107 (SEQ. ID. NO. 2 from nucleotide number 1701 to 1939) is functional when engineered into transgenic plants, and is qualitatively equivalent to the full-length GS3A promoter in its expression. This DNA element comprises three portions: (a) the GS3A promoter element (FIG. 5B, nucleotide residue numbers -132 to -1; SEQ. ID. NO. 2 from nucleotide number 1701 to 1832); (b) the 5' non-translated leader sequence for the GS3A structural gene (FIG. 5B, nucleotide residue numbers 1 to 88; SEQ. ID. NO. 2 from nucleotide number 1833 to 1920); and (c) the first six codons of the GS3A structural gene (FIG. 5B, nucleotide residue numbers 89 to 107; SEQ. ID. NO. 2, from nucleotide number 1921 to 1939).
DNA fragments a201 (FIG. 5B, nucleotide numbers -129 to -97; SEQ. ID. NO. 2, nucleotide numbers 1704 to 1832), a202 (FIG. 5B, nucleotide numbers -129 to -106; SEQ. ID. NO. 2, nucleotide numbers 1704 to 1727) and a206 (FIG. 5B, nucleotide numbers -122 to -106; SEQ. ID. NO. 2, nucleotide numbers 1711 to 1727) contained within the -132 GS3A
promoter element (shown in FIG. 11A) bind to a proteinaceous factor, GS3A-F1, found in whole-cell extracts of pea, and nuclear extracts of pea and tobacco (see Section 7.2.3., infra) . Nuclear and whole cell plant extracts were analyzed by DNA mobility-shift techniques to identify this novel protein which bound to a 17 bp DNA element contained within the -132 GS3A promoter element (FIG. 5B from nucleotide residue number -122 to -106; SEQ. ID. NO. 2 nucleotide numbers 1711 to 1727), having the following sequence:
TTGATCTAGTAGATAAA.
The present invention provides for recombinant DNA constructs which contain nucleotide sequences substantially as depicted in FIGS. 5A, 5B, or 5C (SEQ. ID. NOS. 1, 2 or 3, respectively), functional portions thereof, and nucleotide sequences homologous thereto. Functional portions of the glutamine synthetase promoters described herein refers to regions of the nucleic acid sequence which are capable of promoting transcription under a specific set of conditions, in a particular cell type, or otherwise. Such functional portions include but are not limited to the -132 bp element of the GS3A promoter (supra); the a201, a202 and a206 sequences contained within the -132 GS3A promoter element (supra); and fragments which similarly display functional activity for GS2 or GS3B. Nucleotide sequences homologous to the glutamine synthetase promoters described herein refers to nucleic acid sequences which are capable of hybridizing to the nucleic acid sequences depicted in FIG. 5 (SEQ. ID. NOS. 1, 2 or 3) in standard hybridization assays or are homologous by sequence analysis (containing a span of 10 or more nucleotides in which at least 50 percent of the nucleotides are identical to the sequences presented
herein). Homologous nucleotide sequences refer to
nucleotide sequences including, but not limited to,
glutamine synthetase promoter elements in diverse plant species as well as genetically engineered derivatives of the promoter elements described herein. According to the latter embodiment, it may be found that altering the sequence of the promoter element may result in a change in promoter activity, such as an increase or decrease in promoter strength or a different pattern of cell or organ-specific expression. Such engineered promoter elements may be used, according to the invention, to design optimal gene fusion systems for a variety of applications.
5.3. GENE FUSIONS CONTAINING GLUTAMINE
SYNTHETASE PROMOTER ELEMENTS
The glutamine synthetase promoter elements of the invention may be used to direct the expression of glutamine synthetase or any other protein, referred to as a
heterologous protein or as a desired protein, or the
expression of an RNA product, including, but not limited to, an "antisense" RNA. For example, recombinant constructs containing a glutamine synthetase promoter element as defined in Sections 5.1 and 5.2 supra and a nucleic acid sequence encoding a desired protein are within the scope of the present invention. Such constructs may include the entire GS promoter sequence, or functional portions as described in Section 5.2, ligated to the coding sequence of interest, and may or may not include sequences that encode amino acids of the glutamine synthetase structural gene.
The constructs should be designed so that the nucleic acid encoding the desired protein is in phase with contiguous sequences of GS such that translation will result in an amino acid sequence which correlates with the amino acid sequence of the native form of the desired protein.
In various embodiments of the invention, it may be desirable to include additional nucleotide sequences in the glutamine synthetase promoter recombinant constructs. Such additional nucleotide sequences may include but are not limited to, sequences encoding a ribosome binding site;
sequences encoding 5 ' untranslated leader sequences of mRNA species, including but not limited to the 5' non-translated leader of GS3A (see FIG. 5B, nucleotide residue numbers 188; SEQ. ID. NO. 2 nucleotide number 1834 to 1920) which may confer or enhance phloem-specific expression; an intron; a 3' non-translated sequence, such as a polyadenylation signal; sequences encoding an initiation codon or a signal peptide (which facilitates secretion of the desired
protein); and targeting peptides, such as peptides which target the desired protein to chloroplasts or to the cell nucleus. In preferred embodiments of the invention which utilize the Agrobacterium tumefaciens system for plant transformation, the recombinant construct of the invention may additionally contain the left and right T-DNA border sequences.
In addition, the recombinant constructs of the
invention may include a selectable marker for propagation of the constructs. For example, if the construct is to be propagated in bacteria, it may comprise a gene for
antibiotic resistance. Suitable vectors for propagating the construct would include plasmids, cosmids, and viruses, to name but a few.
5.4. CREATION OF TRANSGENIC PLANTS
CONTAINING RECOMBINANT GLUTAMINE SYNTHETASE PROMOTER ELEMENTS
The recombinant constructs containing a gene of interest placed under the control of the GS promoter
elements described herein may be used to transform cells in culture or to engineer transgenic plants, so that expression of the gene of interest, or transgene is driven by the GS promoter element. In preferred embodiments of the
invention, the Agrobacterium tumefaciens gene transfer system may be used to introduce the recombinant constructs of the invention into plants; generally, this system may be utilized to transfer DNA into dicotyledonous plants (Bevan et al., 1982, Ann. Rev. Genet. 16: 357-384; Rogers et al.,
1986, Methods Enzymol. 118:627-641; Fraley et al., 1986, CRC Crit. Rev. Plant Sci. 4:1-46; Hooykaas et al., 1984, Adv. Genet. 22:210-283; Nester et al., 1984, Ann. Rev. Plant Physiol. 35:387-413). To this purpose, vectors such as, but not limited to, binary Agrobacterium vectors for plant transformation may be utilized, such as, for example, the vector described by Bevan (1984, Nucl. Acids Res. 12:8711- 8721). Xanthi may be transformed by a leaf inoculation procedure such as that described by Horsch et al. (1985, Science 227:1229-1231).
Additional methods for introducing DNA into plants may also be utilized, particularly if the recombinant construct is to be used to create a transgenic monocotyledonous plant. Such methods would include, but are not limited to
poly(ethylene glycol) and calcium-mediated uptake of naked DNA (Hain et al., 1985, Mol. Gen. Genet. 199:161-168;
Paszkowski et al., 1984, EMBO J. 3:2717-2722; Potrykus et al., 1985, Mol. Gen. Genet. 199:169-177), electroporation (Fromm et al., 1985, Proc. Natl. Acad. Sci. U.S.A. 82:5824-5828), microinjection and cell gun.
In order to identify successful transformants, it may be desirable to transform host cells with a second construct which comprises a selectable marker or reporter gene. The second construct may be introduced separately or in tandem with the construct which comprises the glutamine synthetase promoter and the sequence encoding the desired gene product. If not constructed in tandem, the second construct may also comprise a glutamine synthetase promoter, such that
expression of selectable marker or reporter gene function may serve as an indicator of promoter activity and thereby provide evidence that the gene encoding the desired gene product is actively transcribed. This may be useful when a desired protein may have activity which is difficult to identify (e.g. the desired protein influences crop yield). Selectable markers would include genes which engender antibiotic resistance (for example, kanamycin resistance) or which encode a reporter gene, including but not limited to the gene for beta-glucuronidase (Jefferson, 1987, Plant Mol. Bio. Rep. 5:387-405), neomycin phosphotransferase (NPT II), and luciferase (Ow et al., 1986, Science 234:856-859) to name but a few. Detection of reporter gene expression may then be performed using methods known in the art.
Alternatively, transformants may be tested for the presence of recombinant construct by methods which would identify foreign DNA sequences, such as the Southern blot procedure. Transcription of recombinant constructs could be detected by isolating RNA from the transformant and
screening for the expected transcript by Northern blot or RNA protection experiments (see Section 6.1.6., infra).
Likewise, translation of the desired protein could be detected by protein gel electrophoresis, Western blot techniques, immunoprecipitation or enzyme-linked
immunoassays.
Using similar techniques, the expression of the recombinant constructs of the invention may be detected in specific plant organs or tissues by determining the presence of RNA, protein, selectable marker, or reporter gene which may serve as an indicator of transcription resulting from recombinant glutamine synthetase promoter activity.
In specific embodiments of the invention, the GS2 promoter or GS2 homologous sequences may be detectably active in tissues such as photosynthetically active cells, including the palisade and spongy parenchymal cells of the leaf blade, in collenchymal and chlorenchymal cells of the stem, in photosynthetic cotyledons, and, at low levels, in root tips. Light-enhanced promoter activity may be
detected. In a specific embodiment of the invention, tissue specific and light-enhanced activity of the GS2 promoter and its equivalents may be detected by the expression of the reporter gene beta-glucuronidase (Jefferson, 1987, Plant Mol. Biol. Rep. 5:387-405' see Section 6, infra).
In further embodiments of the invention, the GS3A or GS3B promoters or homologous sequences may be detectably active in vascular tissues such as leaves, stems, and roots of the mature plant, and in the cotyledons and roots of developing seedlings. In a specific embodiment of the invention, tissue specific activity of the GS3 promoters and their equivalents may be detected by the expression of the reporter gene beta-glucuronidase (Jefferson, 1987, Plant Mol. Biol. Rep. 5:387-405; see Section 6, infra).
5.5. UTILITY OF THE INVENTION
The present invention may be utilized to direct the expression of glutamine synthetase or heterologous proteins using novel plant organ specific promoter elements.
According to specific embodiments of the invention, the GS2, GS3A, or GS3B promoter elements, functional portions
thereof, or sequences homologous thereto, (as described supra) may be used to direct the expression of glutamine synthetase or heterologous gene products via recombinant nucleic acid- constructs.
In particular embodiments of the invention, the novel promoter elements may be used to direct the expression of glutamine synthetase. Such embodiments may be useful in the engineering of plants which are genetically deficient in endogenous synthesis of glutamine synthetase or which may benefit from over production of glutamine synthetase, and may be used to introduce an isoenzyme of glutamine
synthetase into a cellular compartment normally occupied by an alternate isoenzyme. Furthermore, engineered forms of the promoters of the invention which result in greater activity or altered tissue distribution of promoter function, may be used to alter expression patterns of glutamine synthetase. Manipulation of glutamine synthetase production may be advantageously used to confer herbicide resistance (see infra).
According to particular embodiments of the invention, the GS2 promoter and its functional or homologous
equivalents may be used to provide tissue specific and light enhanced expression of desired proteins or gene products (e.g., antisense RNA). The GS2 promoter is selectively active in photosynthetic tissues. The tissue selectivity of the GS2-like promoters may be utilized to express desired proteins or gene products in photosynthetic tissues. The gene products may impact on the physiology of the plant (i.e., alter the size, growth rate, or density of
photosynthetic tissues) or may introduce a molecule which does not naturally occur in the tissue, such as an insect repellant or fungus-retardant agent. The fact that GS2 promoter activity is enhanced by light provides the
opportunity to control the onset, duration, and termination of expression of a desired gene product; this capability may be especially useful when a critical period of development of a plant or plant product exists and exposure to a gene product (e.g. a growth hormone expressed under the control of a GS2 promoter) may optimally be used to alter the properties of the plant or plant product.
According to further particular embodiments of the invention, the GS3 promoters and their functional or
homologous equivalents may be used to provide phloem
specific expression of desired proteins or gene products. Phloem specific expression of desired gene products may be used, for example, to alter plant metabolism; since plant nutrients (carbon and nitrogen-containing compounds) are transmitted via the phloem, expression of foreign genes specifically within the phloem could be used to increase the efficiency of nutrient uptake. In further embodiments of the invention, phloem-specific expression could be utilized in the mass production of foreign proteins (including, for example, lymphokines or antibody molecules) which could be recovered from the phloem exudate by "bleeding".
GS2 and GS3 promoter elements may be.useful in imparting resistance to viral diseases to transgenic plants. Although viral infection in plants is not completely
understood, it is believed that viruses move through plants either by short distance cell to cell spread (through plasmodesmata) or by dissemination over longer distances via the plant vascular system. It has been suggested that if a virus has a specific relationship to a plant tissue, it is most commonly associated with phloem tissue; both phloem- specific as well as nonrestricted viruses have been
identified in the phloem (Esau, 1969, in "The Phloem,"
Gebruder Borntraeger, Berlin, pp. 252-262). A role for viral coat protein in preventing long-distance transport of virus has been observed in a variety of systems. Plants transformed to express tobacco mosaic virus protein were found to be resistant to tobacco mosaic virus infection;
interestingly, efficient movement of virus through plant stem was found to be prevented by grafting a section of plant expressing viral coat protein into the movement path of the virus (Baulcombe and Hull, 1989, Nature 341:189).
Turner et al. (1987, EMBO J. 6: 1181-1181) found that tobacco and tomato plants which expressed chimeric alfalfa mosaic virus (AlMV) coat protein were significantly delayed in symptom development after exposure to infectious A1MV, and some escaped infection altogether. Hemenway et al., (1989, in "Discoveries in Antisense Nucleic Acids," Brakel, ed., Gulf Publication Co., Houston, TX, pp. 165-174) demonstrated protection against virus infection in transgenic plants expressing the viral coat protein or corresponding antisense RNA from tobacco mosaic virus, cucumber mosaic virus, and potato virus X. In specific embodiments of the invention, the GS2 and/or GS3 promoter elements may be used to express viral coat protein or the corresponding antisense mRNA in viral target tissues. Since viral spread appears to occur, at least in part, via the phloem, in a preferred embodiment a GS3 promoter element may be used to direct phloem-specific expression of a viral coat protein or its corresponding mRNA.
Furthermore, non-viral pathogens including
mycoplasma-like organisms (MLO's) are also transmitted by phloem. MLO's cause a severe plant disease called "yellows" which devastates many citrus crops. GS3 phloem specific promoter may be used to express protein or nucleic acid which negatively affects MLO expression.
In still further embodiments of the invention, GS2 and GS3 promoter elements may be used to develop plants which are resistant to herbicides. Like viruses, many herbicides are transported through plants via phloem tissue.
Furthermore, many of the newer, highly potent herbicides inhibit plant growth by interfering with the biosynthesis of essential amino acids rather than by inactivating a
component of the photosynthetic apparatus (Shah et al., 198, in "Temporal and Spatial Regulation of Plant Genes", Verma and Goldberg, eds., Springer-Verlag, NY); as a result, these new herbicides have a broad spectrum of activity which discriminates poorly between weeds and crops. Several of these herbicides are directed at glutamine synthetase activity and/or are directed toward enzyme expressed in chloroplasts.
For example, glyphosate (N-[phosphonomethyl]glycine) is a broad spectrum nonselective herbicide which inhibits 5-enolpyruvylshikimate-3-phosphate (EPSP) synthase, an enzyme normally localized in the chloroplast; overproduction of unaltered or altered EPSP synthase, targeted to
chloroplasts via a transit peptide, appeared to inhibit glyphosate toxicity (Shah et al:, 1986, Science 233:478-481; Steinrucken and Amrhein, 1980, Biochem. Biophys. Res.
Commun. 94:1207; Rubin et al., 1984, Plant Physiol. 75:839).
Phosphinothricin, a herbicide derived from a
Streptomyces tripeptide antibiotic is structurally similar to glutamine and glutamate, and is a competitive inhibitor of glutamine synthetase (La Rossa and Falco, 1984, Trends in Biotechnology 2:158-161). Inhibition of phosphinothricin causes rapid accumulation of ammonia which is toxic to the plant (Tachibana et al., 1986, J. Pest. Sci. 11:33-37). A mutant of alfalfa tissue which overproduces glutamine synthetase has been observed to be resistant to the effects of the herbicide (Donn et al., 1984, J. Mol. Appl. Genet. 2:621-635). Similarly, a gene that encodes the detoxifying enzyme phosphinothricin acetyl transferase has been cloned; when expressed in calli, under the control of the CamV 35S promoter, the calli are resistant to the herbicide.
Sulfonylurea herbicides inhibit the activity of acetolactate synthase (ALS), a nuclear-encoded chloroplast localized enzyme (Chaleff and Ray, 1984, Science 223:1148-1151; Jones et al., 1985, Plant Physiol. 77:S293).
Mutations of the ALS gene which have resulted in resistance to sulfonylurea herbicides have been reported (Yadav et al., 1986, Proc. Natl. Acad. Sci. U.S.A. 83:4418-4422).
Resistance to atrazine (Cheung et al., 1988, Proc.
Natl. Acad. Sci. U.S.A. 85:391-395), glyphosate (Comai et al., 1985, Nature 317:741-744), and sulfonylurea herbicides (Haughn et al., 1988, Mol. Gen. Genet. 211:266-271) have been achieved by the introduction of foreign genes encoding modified insensitive target proteins. Alternatively,
resistance to phosphinotricin (De Block et al., 1987, EMBO J. 6:2513-2518) and bromoxynil (Stalker et al., 1988, Science 242:419-423) has been achieved by the expression of detoxifying enzymes. (See Streber and Willmitzer, 1989, Bio/Technology 7:811-815 for review).
In various embodiments of the invention, the GS2 and/or GS3 promoters may be used to achieve herbicide resistance in the herbicide target tissues. Thus, GS3 promoters may be used to achieve glutamine synthetase overproduction or the expression of inhibitory substrate or detoxifying enzyme in the phloem, the avenue of transport for most herbicides. Similarly, G2S promoters may be used to direct the expression of glutamine synthetase, inhibitory substrate or detoxifying enzyme in photosynthetic tissue; in specific embodiments, the glutamine synthetase, inhibitory substrate or detoxifying enzyme may be targeted to the chloroplasts via a transit peptide when herbicides are toxic to a chloroplast enzyme. The use of the GS2 and GS3
promoters of the invention focuses anti-herbicide activity to the tissue compartment most affected by herbicide instead of altering the physiology of the entire plant. For
example, overproduction of glutamine synthetase throughout a plant may result in aberrancies of nitrogen metabolism, whereas overproduction in one tissue compartment would not. Furthermore, it may be possible to inhibit herbicide action using a mutant form of glutamine synthetase or an isoenzyme not normally found in a particular compartment, thereby minimizing the interference with endogenous isozenyme activity.
6. EXAMPLE: IDENTIFICATION OF MESOPHYLL-SPECIFIC
AND PHLOEM-SPECIFIC PROMOTER ELEMENTS 6.1. MATERIALS AND METHODS
6.1.1. ISOLATION OF GLUTAMINE SYNTHETASE GENOMIC CLONES Genomic clones encoding chloroplast or cytosolic GS of pea were isolated from a genomic library of Pisum sativum cv. "Sparkle" (Rogers Brothers Seed Co., Twin Falls, ID) constructed in "Lambda Dash" (Stratagene, La Jolla, CA).
Complete sequence analysis of each genomic clone revealed that the genomic clone for chloroplast GS2 (GS2ct)
corresponds to the GS185 cDNA (Tingey et al., 1988, J. Bio.
Chem. 263:9651-9657), while the genomic clone for cytosolic
GS (GS3Acy) corresponds to the GS341 cDNA (Tingey et al.,
1988, J. Bio. Chem. 263:9651-9657).
6.1.2. CONSTRUCTION OF PLASMIDS AND
TRANSFORMATION OF AGROBACTERIUM
A 1.5 kb EcoRI-Hindi fragment of the promoter region of the pea nuclear gene for chloroplast GS2 (GS2ct) was inserted into the polylinker of pBI101.2 (Jefferson, 1987, plant Mol. Bio. Rep. 5:387-405) (Clontech, Palo Alto, CA) to create the plasmid, pGS2ct-GUS (Fig. 1A). In addition to the promoter region of GS2, pGSct-GUS contains approximately
65 nt of the 5' untranslated leader of the GS2 mRNA and encodes 53 amino acids of the chloroplast transit peptide (Tingey et al., 1988, J. Bio. Chem. 263:9651-9657). The
GS3Acy-GUS fusion was constructed by inserting a 1.01 kb DNA fragment encompassing nucleotide position -903 to a BglII site at position +107 of the GS3Acy gene ,into the BamHI site upstream of the GUS gene in pBI101 (Jefferson, 1987, Plant Mol. Bio. Rep. 5:387-405)- Tne GS3Acy-GUS fusion gene was released from the plasmid as an Xbal-EcoRI fragment which was subsequently cloned into pMON505 (Horsch and Klee, 1986, Proc. Natl. Acad. Sci. USA. 83:4428-4432) to create the plasmid, ρGS3Acy-GUS (Fig. 1B). pGS3Acy-GUS contains 88 nt of the 5' untranslated leader of GS3A mRNA and encodes six amino acids of the cytosolic GS protein (Tingey et al., 1988, J. Bio. Chem. 263:9651-9657).
6.1.3. TRANSFORMATION AND GROWTH OF
TRANSGENIC TOBACCO PLANTS
Binary vectors containing the GS-GUS constructs were transferred into the disarmed Agrobacterium stain LBA4404 by triparental mating as previously described (Bevan, 1984, Nucleic Acids Res. 12:8711-8721). Nicotiana tabacum cv. SRI or Nicotiana tabacum cv. Xanthi was transformed by a leaf inoculation procedure (Horsch et al., 1985, Science
227:1229-1231). Regenerated shoots were selected for growth on medium containing kanamycin (200 μg/ml). Primary
transformants were maintained in sterile culture and were also grown to maturity in soil. F1 seeds were sterilized in 10% sodium hypochlorite and germinated on MS medium
containing 3% sucrose, 100 μg/ml kanamycin, and 500 μg/ml carbenicillin. Seedlings were grown in culture for several days at 26°C in continuous white light.
6.1.4. DETERMINATION OF BETA-GLUCURONIDASE EXPRESSION GUS enzyme assays and histochemical staining of mature plants were performed as previously described (Jefferson, 1987, Plant Mol. Bio. Rep. 5:387-405; Jefferson et al.,
1987, EMBO J. 6:3901-3907). The whole mount histochemical staining of seedlings was performed as previously described (Benfey et al., 1989, EMBO J. 8:2195-220^). After
incubation with the GUS substrate, 5-bromo-4-chloro-3-indolyl-B-D-glucuronic acid (Clontech, Palo Alto, CA), cross sections of mature plant organs and whole seedlings were cleared for chlorophyll by incubation with a solution of 5% formaldehyde, 5% acetic acid, and 20% ethanol for 10 minutes followed by 2 minute incubations with, respectively, 50% and 100% ethanol. Photomicrographs were taken with a Nikon Optiphot microscope using phase- contrast optics.
6.1.5. PLANT GROWTH CONDITIONS FOR
LIGHT INDUCTION EXPERIMENTS
Transgenic plants containing the GS2ct-GUS fusion gene were germinated and grown in soil in continuous white light for 4 weeks. The plants were transferred to black Lucite boxes within a dark environmental chamber for 4 days.
Several leaves of each plant were collected in the dark and immediately frozen in liquid nitrogen. The plants were subsequently transferred to continuous white light for 24 hours and leaves were collected and frozen for RNA
extraction.
6.1.6. ISOLATION OF RNA AND RIBONUCLEASE
PROTECTION ASSAY
RNA was extracted from leaves of dark-adapted and light-grown transgenic tobacco plants using guanidine thiocyanate as a protein denaturant (Chirgwin et al., 1979, Biochem. 12:5294-5304). The DNA vector used (pJE1005) contained a 1.5 kb EcoRI-HincII fragment of the nuclear gene for chloroplast GS2 (GS2ct) in the plasmid pTZ18U (US
Biochemical, Cleveland, OH). A DNA template encompassing the 5' end of GS2ct was generated by HindIII digestion of pJE1005. The radioactive, antisense RNA probe for the RNAse protection assay was generated in vitro using T7 RNA
polymerase (Melton, 1984, Nucleic Acid Res. 12:7035-7056). 50 μg of total RNA from transgenic tobacco plants was hybridized to an excess of the antisense RNA probe overnight in 80% formamide, 60 mM Pipes pH 6.4, 400 mM NaCl and 1 mM
EDTA at 60°C. RNAse T2 digestions were performed in a volume of 390 μl containing 50 mM NaOAc pH 5.0, 100 mM NaCl, 2 mM EDTA, and 60 units/ml of RNAse T2 (Bethesda Research Labs.) (Costa et al., 1989, EMBO J. 8:23-29). Digestion products were separated on an 8% acrylamide/7M urea gel and exposed to X-Ray film at -80°C.
6.2. RESULTS
6.2.1. CONSTRUCTION OF GS-GUS REPORTER GENE FUSIONS
AND QUANTIFICATION OF BETA-GLUCURONIDASE
ACTIVITY IN TRANSGENIC PLANTS
Genomic clones encoding chloroplast or cytosolic GS of pea were isolated by hybridization to the corresponding cDNAs, pGS185 (Tingey et al., 1988, J. Bio. Chem. 263:9651- 9657) and pGS341 (Tingey et al., 1988, J. Bio. Chem.
263:9651-9657), respectively. The genomic clone pGS2ct corresponds to the single nuclear gene for chloroplast GS2
(Tingey et al., 1988, J. Bio. Chem. 263:9651-9657). The genomic clone pGS3Acy corresponds to a gene for cytosolic GS
(GS341) which encodes the predominant mRNA for cytosolic GS in a number of organs examined. Promoter elements from the gene for chloroplast GS2 and cytosolic GS3A were subcloned in translational fusions to the GUS reporter gene of
pBI101.2 or pBIlOl, respectively, as described in Materials and Methods (Jefferson, 1987, Plant Mol. Bio. Rep. 5:387- 405) to create ρGS2ct-GUS and pGS3Acy-GUS (Fig. 1). These chimeric genes were introduced into Nicotiana tabacum via
Agrobacterium mediated plant transformation (Bevan, 1984,
Nucleic Acids Res. 12:8711-8721).
GUS enzyme activity was measured in soluble protein extracts of leaves of 19 individual transgenic plants by a fluorimetric assay (Jefferson, 1987, Plant Mol. Bio. Rep.
5:387-405; Jefferson et al., 1987, EMBO J. 6 :3901-3907)
(Table I). GUS activity in leaves of primary transgenic plants contai .ni.ng the pGS2ct-GUS construct averaged 46,984 pmol MU/mg protein/min, while GUS activity detected in the leaves of transgenic plants containing the pGS3Acy-GUS chimeric construct was approximately 17-fold lower. The amount of GUS activity produced in transgenic plants containing pGS2ct-GUS is comparable to that reported for other "strong" promoters such as that for the cauliflower mosaic virus 35S protein (Benfey et al., 1989, EMBO J.
8:2195-2202) and patatin (Rocha-Sosa et al., 1989, EMBO J.
8 : 23-29) .
TABLE I GUS Activity in Leaves of Transgenic Tobacco Plants pmol MU/mg protein/min
Chloroplast GS2ct -GUS Transformants Cytosolic GS3Acy-GUS Transformants pGS2ct-GUS-1 13,070 pGS3Acy-GUS-1 2,183 pGS2ct-GUS-2 22,374 pGS3Acy-GUS-2 9,429 pGS2ct-GUS-3 53,155 pGS3Acy-GUS-3 1,940 pGS2ct-GUS-4 67,300 pGS3Acy-GUS-4 372 pGS2ct-GUS-5 60,373 pGS3Acy-GUS-5 648 pGS2ct-GUS-6 32,918 pGS3Acy-GUS-6 2,453 pGS2ct-GUS-7 43,084 pGS3Acy-GUS-7 1,740 pGS2ct-GUS-8 53,886
pGS2ct-GUS-9 40,802
pGS2ct-GUS-10 95,435
pGS2ct-GUS-11 43,568
pGS2ct-GUS-12 37,840
Average 46 , 984 Average 2 , 681
*MU - Methylumbelliferone Southern blot experiments using DNA from transgenic tobacco containing pGS2 -GUS or pGS3Acy-GUS revealed that each transformed plant contained 1 or 2 copies of the transgene. The variation in the amount of GUS activity between individual transgenic plants was 7-fold for the pGS2ct-GUS plants, and 25-fold for the pGS3Acy-GUS plants (Table I). This degree of variation in GUS expression among individual transgenic plants is similar to that reported by others (Benfey et al., 1989, EMBO J. 8:2195-2202; Rocha-Sosa et al., 1989, EMBO J. 8:23-29), and is most likely the result of differences in positional insertion in the tobacco genome, or differences in the developmental stages of each plant used in this analysis.
6.2.2. THE PROMOTER FOR CHLOROPLAST GS2
DIRECTS GUS EXPRESSION SPECIFICALLY IN PHOTOSYNTHETIC CELL TYPES
In situ GUS assays were performed on sections of leaves, stems, and roots of mature transgenic tobacco plants (Fig. 2) and on whole tobacco seedlings (Fig. 3). These assays revealed that pGS2ct-GUS or pGS3Acy-GUS confer non-overlapping patterns of cell- and organ-specific expression on the GUS reporter gene in transgenic plants.
In situ staining of sections of the pGS2ct-GUS
transgenic plants reveals that the promoter for chloroplast GS2 directs high-level GUS expression in leaves,
specifically in the parenchymal cells of the leaf blade (Fig. 2A). The most intense GUS staining occurs in the palisade parenchymal cells of the leaf blade which are specialized for photosynthesis and contain a large number of chloroplasts (Fig. 2B). In a cross section of the leaf midrib pGS2ct-GUS activity is detected only in two
photosynthetic cell layers (collenchyma and chlorenchyma), while the adjacent epidermal cell layer comprised of non- photosynthetic cells, shows no GUS expression (Fig. 2C).
There is no GUS expression in the central vascular bundle of the midvein in the pGS2ct-GUS plants (Fig. 2A). In cross sections of stem, GUS activity is detected in the
photosynthetic chlorenchymal cells (Fig. 2D), while there is no GUS staining in the pith parenchymal, vascular,
epidermal, or trichome cells of the stem (Fig. 2D). In roots, pGS2ct-GUS is expressed at low levels in root tips where GS in plasmids functions in ammonia assimilation from the soil (Miflin, 1974, Plant Physiol. 54:550-555).
6.2.3. THE PROMOTER FOR A CYTOSOLIC GS GENE DIRECTS
GUS EXPRESSION EXCLUSIVELY IN PHLOEM
Analysis of the pGS3cy-GUS transgenic plants reveals that the promoter for cytosolic GS directs expression of GUS specifically within the vascular elements of leaves, stems, and roots of mature plants (Fig. 2E-2H). In leaves of pGS3cy-GUS transgenic tobacco, histochemical staining for
GUS occurs exclusively in the vasculature, in a punctate pattern indicative of phloem-specific expression (Fig. 2E and 2F). In roots, the triarc staining pattern observed for pGS3cy-GUS is also indicative of phloem-specific expression
(Fig. 2G). This punctate pattern of GUS expression is also observed in a stem cross section where the internal phloem stains intensely (Fig. 2H).
6.2.4. EXPRESSION OF THE GS-GUS FUSIONS IN
GERMINATING TRANSGENIC TOBACCO SEEDLINGS
To examine the organ and cell-specific expression of pGS2ct-GUS and pGS3cy-GUS during plant development, GUS enzyme activity was detected in situ in whole mounts of germinating tobacco seedlings (Benfey et al., 1989, EMBO J.
8:2195-2202). This analysis reveals a striking contrast between the expression patterns conferred by the promoters for chloroplast GS2 and cytosolic GS3A (Fig. 3). In
transgenic tobacco seedlings containing pGS2ct-GUS, intense
GUS staining is seen throughout the cotyledons, which are photosynthetic in tobacco (Avery, 1932, Am. J. Bot. 20:309- 327) (Fig. 3A). In pea cotyledons, which are non-photosynthetic (Lovell (1977) in The Physiology of the
Garden Pea, eds. Sutcliffe, J. & Pate, J. S. (Academic
Press, London), pp. 265-290), there is low level expression of the mRNA for chloroplast GS2. Therefore, expression of chloroplast GS2 correlates with photosynthetic capacity rather than strict organ-type. In these same pGS2ct-GUS seedlings, GUS activity is not detected in the hypocotyl
(Fig. 3A), and is present at very low levels in the root tips (Fig. 3A).
For cytosolic GS, pGS3Acy-GUS constructs are expressed exclusively in vasculature of developing transgenic
seedlings (Fig. 3B). This vasculature-specific staining pattern is most intense in the cotyledons and is also evident in the hypocotyl and root (Fig. 3B). The emerging leaves of pGS3Acy-GUS transgenic seedlings do not contain detectable levels of GUS (Fig. 3B). The absence of GUS expression in these young leaves is consistent with the apparent lack of vascularization of leaves in these young seedlings (Pato et al., 1970, Protoplasma 71:313-334). As the seedlings mature, and the leaves become vascularized,
GUS activity is detected in the vasculature of pGS3Acy-GUS transgenic seedlings. Control, F1 seedlings derived from plants transformed with a "promoter-less" GUS construct
(pBI101) show no detectable GUS activity in histochemical assays. (Fig. 3C). 6.2.5. THE CHLOROPLAST GS2 PROMOTER CONFERS LIGHT- REGULATED EXPRESSION ON THE GUS REPORTER GENE
Previous results have demonstrated that white light induces the accumulation of the mRNA for chloroplast GS2 in mature pea plants and in etiolated seedlings (Edwards and
Coruzzi, 1989, Plant Cell 1:241~248). To determine whether the promoter for chloroplast GS2 is responsible for the light-induced accumulation of the mRNA for chloroplast GS2, the amount of GS2ct-GUS RNA from transgenic plants grown in the light or dark was measured in a ribonuclease protection assay (Fig. 4). In two separate transgenic plants assayed, the amount of RNA corresponding to the chloroplast GS2-GUS chimeric RNA drops to undetectable levels when the mature light-grown plants are placed in the dark for 4 days (Fig. 4, lanes 1 and 3). When the dark-adapted plants are
returned to white light for 24 hours, the GS2ct-GUS mRNA accumulates approximately 8-fold (Fig. 4, lanes 2 and 4).
In control plants transformed with pBI101 and grown in continuous white light, no cross-hybridization of the RNA probe with the endogenous tobacco GS mRNA is observed (Fig.
4, lane 5). The white-light induction of the steady-state levels of GS2ct-GUS mRNA in transgenic plants demonstrates that cis-acting elements involved in the light regulation of the pea GS2ct gene are contained within a 1.5 kb promoter fragment.
6.3. DISCUSSION
Historically it has been difficult to assess the relative functions of chloroplast and cytosolic GS due to their similarities in physical properties, as well as their immunological cross reactivity. Here, the ability to localize gene expression at the single-cell level reveals that GS isoforms function in different cell types which have distinct nitrogen metabolic needs. These molecular studies have addressed previously unanswered questions concerning the cell-specific location of glutamine synthesis during plant development.
Here we have demonstrated that the promoters from the nuclear genes for chloroplast GS2 and cystolic GS3A of pea confer unique, cell-specific patterns of expression on a GUS reporter gene in transgenic tobacco plants. The promoter for chloroplast GS2 directs GUS gene expression
predominantly within photosynthetically active cells, the palisade and spongy parenchymal cells of the leaf blade, in collenchymal and chlorenchymal cells of the stem, and in photosynthetic tobacco cotyledons. By contrast, the
promoter for cytosolic GS3A confers vasculature-specific GUS expression in leaves, stems, and roots of the mature plant, and in the cotyledons and roots of developing seedlings. These non-overlapping patterns of GUS expression signify that the chloroplast GS2 and cytosolic GS3A isoforms perform separate functions in plant nitrogen metabolism.
The activity of the promoter for chloroplast GS2 predominantly in photosynthetic cell types is consistent with previously reported findings that chloroplast GS2 functions in the reassimilation of photorespiratory ammonia (Wallsgrove, et al., 1987, Plant Physiol. 83:155-158;
Edwards et al., 1989, Plant Cell 1:241-248), and the
assimilation of reduced nitrite in plasmids (Miflin, B.J., 1974, Plant Physiol. 54 :550-555). Previous analysis of photorespiratory mutants revealed that plants which lacked chloroplast GS2 were inviable when grown under
photorespiratory conditions even though they contained normal levels of cytosolic GS (Wallsgrove et al., 1987, Plant Physiol. 83:155-158). It has also been shown that mRNA for the chloroplast GS2 accumulates preferentially in plants grown under photorespiratory conditions whereas the levels of cytosolic GS mRNAs are unaltered (Edwards et al., 1989, Plant Cell 1:241-248). The results presented here indicate that the genes for chloroplast GS2 (GS2ct) and cystolic GS (GS3Acy) are expressed in distinct cell types.
Therefore, in the previous analysis of photorespiratory mutants, the inability of cytosolic GS to compensate for the loss of the chloroplast GS2 activity in photosynthetic cells of mutant plants (Wallsgrove, et al., 1987, Plant Physiol. 83:155-158) may be explained by the fact that cytosolic GS and chloroplast GS2 are expressed in separate cell types, as demonstrated here. The expression of chloroplast GS2 and cytosolic GS in separate cell types may also explain why cytosolic GS gene expression is unaffected by the generation of photorespiratory ammonia (Edwards et al., 1989, Plant Cell 1:241-248). It will be interesting to determine whether expression of a GS isoform within the cytoplasm of photosynthetic cell types can functionally replace
chloroplast GS2 in the reassimilation of photorespiratory ammonia.
The unforeseen finding of this transgenic analysis was the confinement of cytosolic GS3A gene expression
exclusively to the vascular elements. This result has elucidated the role of this cytosolic GS isoform in plant development. While glutamine serves as a major compound for intercellular nitrogen transport in higher plants, and is found in high levels in both the xylem and phloem saps (35), its source of synthesis was heretofore unknown. From the transgenic data presented here, it is apparent that at least one cytosolic GS isoform is expressed exclusively in the phloem elements and most likely functions to generate glutamine for intercellular nitrogen transport. The high-level expression of the gene for cytosolic GS3A in the vasculature is particularly intense in the cotyledons of germinating seedlings where glutamine serves to transport nitrogen from seed storage reserves to the developing plant. These findings in transgenic tobacco correlate well with the abundant accumulation of mRNA corresponding to this gene for cytosolic GS in germinating pea cotyledons and in nitrogen-fixing nodules (Tingey et. al., 1987, EMBO J. 6:1-9), two contexts where large amounts of glutamine are synthesized for nitrogen transport (Lea et al., 1983, in Recent Advances in Phytochemistry: Mobilization of Reserves in Germination, eds. Nozzolillo, C. , Lea, P.J. & Loewus, F.A. (Plenum Press, NY, pp. 77-109); Pate et al., 1969, Planta 85:11-34). Since expression of pea cytosolic GS3A in tobacco cotyledons is confined to the vasculature, it will be of interest to determine whether induced expression of this cytosolic GS isoform in pea nodules correlates with the vascularization of this organ. Recently, it has been shown that promoters for two cytosolic GS genes of Phaseolus vulgaris can direct expression in transgenic Lotus corniculatus nodules, and that one of these promoters is active in vascular and cortical cells of the nodule (Forde et. al., 1989, Plant Cell 1:391-401).
The quantification of GUS activity detected in whole leaf extracts of plants transformed with either pGS2ct-GUS of pGS3Acy-GUS revealed that plants containing the
chloroplast GS2ct-GUS transgene contained, on average, 17 times more GUS activity than plants containing the GS3Acy- GUS construct. However, because the expression of each of the GS-GUS constructs is confined to distinct leaf cell types which comprise different fractions of the total leaf cell population, the relative amount of GUS activity in whole leaf extracts cannot be regarded as a measure of absolute promoter strength.
The light-induced accumulation of the transgenic
GS2ct-GUS mRNA reveals that the promoter for GS2ct contains a cis-acting DNA element involved in light regulation.
Since previous experiments have demonstrated that phytochrome is partially responsible for the white-light induction of the mRNA for chloroplast GS2 (Tingey et al.,
1988, J. Bio. Chem. 263:9651-9657; Edwards et al., 1989, Plant Cell 1:241-248). studies of the promoter for GS2ct should contribute to the understanding of phytochrome- mediated gene expression. It is noteworthy that plastid GS2 is also present in non-photosynthetic cell types such as etiolated leaves (Hirel, 1982, Planta 155:17-23) and roots
(Miflin, 1974, Plant Physiol. 54:550-555). This is
corroborated by the low-level of GUS expression in roots of pGS2ct-GUS transgenic plants. Therefore, the regulation of expression of the GS2ct gene is likely to differ from that of other light-regulated genes which function solely in photosynthesis (e.g. ribulose 1,5 bis-phosphate carboxylase, chlorophyll a/b binding protein).
The unique expression patterns conferred upon the GUS reporter gene by the promoters for chloroplast GS2 and cytosolic GS3A and the light-regulated induction of pGS2ct- GUS RNA levels are most likely due to the transcriptional regulation of these transgenes. However, because the GS-GUS fusions contain the 5' noncoding leader of the GS mRNAs and a small portion of the GS coding regions, it is possible that post-transcriptional events (e.g. RNA stability, translational regulation, and subcellular
compartmenalization) also contribute to the observed
differences in transgene expression. Future experiments directed at characterizing the specific cis-acting
regulatory regions of the GS genes will distinguish between these possibilities.
In addition to elucidating the individual roles of the
GS isoforms in plant nitrogen metabolism, the transgenic studies presented here describe plant promoters which may be used to direct cell-specific expression of foreign genes in plants. In particular, a promoter which confers specific expression of foreign genes in phloem cells has potential application in generating resistance to viral pathogens transmitted within the phloem (Schneider, 1965, 11:163-221). Finally, since glutamine synthetase is the target of several herbicides (Kishore, et al., 1988, 57:627-663), the
expression studies presented here indicate that it may be necessary to express herbicide resistant forms of GS in bot photosynthetic and vascular cell types in order to confer resistance to GS inhibitors.
Nucleotide analysis of the GS genes in P. sativum has shown that chloroplast and cytosolic GS are derived from duplications of a single ancestral gene followed by
specialization of each locus for distinct expression (Tinge et al., 1988, J. Bio. Chem. 263:9651-9657; Coruzzi et al., 1989, in The Molecular Basis of Plant Development, Alan R. Liss, Inc., pp. 223-232). Future studies directed at the identification of the necessary cis-acting promoter regions of the nuclear genes for chloroplast and cytosolic GS shoul uncover DNA elements which have evolved to confer distinct spacial and temporal patterns of expression to these genes.
7. EXAMPLE: IDENTIFICATION OF A REGION OF
THE GS3A PROMOTER REQUIRED FOR EXPRESSION
IN TRANSGENIC PLANTS AND A DNA-BINDING
PROTEIN WHICH BINDS TO THIS GS3A ELEMENT
In the examples detailed below, the DNA sequence of the pea cytosolic glutamine synthetase GS3A gene promoter was determined and the start of transcription mapped using
SI nuclease. The full-length promoter and a series of 5' deletions were ligated to β-glucuronidase (GUS) and
introduced into transgenic tobacco and alfalfa; In
transgenic tobacco, the GS3A promoter directed GUS
expression in the phloem cells of the vasculature in leaves, stems, and roots. GUS expression was also detected in the vasculature of cotyledons, and the root tips of germinating T1 seedlings. The promoter conferred a similar expression pattern in transgenic alfalfa, and expression was also observed in root nodules. Nodule expression was located in nodule primordia, and the meristem, the symbiotic zone, and vasculature of mature nodules. The promoter was found to be active even when deleted to -132 relative to the start of transcription (FIG. 5B, nucleotide number -132; SEQ. ID. NO. 2, nucleotide number 1701). DNA mobility-shift analysis identified a protein present in nuclear and whole cell plant extracts which bound to a 17 bp DNA element contained within the minimal -132 promoter required for expression (FIG. 5B, nucleotide number -122 to -106; SEQ. ID. NO. 2, nucleotide number 1711 to 1727).
The DNA sequence of the promoter of the GS3A gene, the expression patterns the full-length promoter, and a series of 5' deletions in both transgenic tobacco and transgenic alfalfa were analyzed. We identified a region of the promoter which is required for expression in both tobacco and alfalfa and which directs GUS expression at high levels in cotyledons and nodules. This promoter fragment was subsequently used to identify a novel DNA-binding protein present in nuclear and whole-cell plant extracts.
7.1. MATERIALS AND METHODS
7.1.1. DNA CLONING AND SEQUENCING
A clone carrying a 5.76 kb insert was isolated from a genomic library of Pisum sativum cv. 'Sparkle' constructed in 'lambda dash' (Stratagene) using the GS3A (a.k.a. GS341) cDNA as a hybridization probe (Tingey et al., 1987, EMBO J. 6: 1-9). Standard procedures were used for library
screening and plaque purification. The 5.76 kb insert was transferred to pEMBL18 for sequencing using the dideoxy chain-termination (Biggin et al., 1983, Proc. Natl. Acad. Sci. USA 80: 3963-3965; Murphy and Kavanagh, 1988, Nuc.
Acids. Res. 16: 5198).
7.1.2. S1 NUCLEASE MAPPING
The transcriptional start site of the GS3A promoter was mapped by 5' SI analysis. A uniformly labelled DNA probe was prepared using the oligonucleotide EW1 (extending from +85 to +104) as a primer on a GS3A genomic clone template corresponding to the deletion A16 cloned in
M13mpl8. Restriction digestion of the labelled product within the M13mpl8 polylinker yielded a probe of 332 bp.
This DNA probe was hybridized to total RNA from leaves, roots, 21 day old nodules and cotyledons of 5 day old seedlings, all from pea. Following incubation with SI nuclease, the products were separated on a 5% denaturing polyacrylamide sequencing gel. Dideoxy sequencing reactions of the DNA probe also primed by EW1 were run alongside the SI nuclease digestion products.
7.1.3. CONSTRUCTION OF PROMOTER-GUS FUSIONS A GS3A promoter-containing fragment extending from the BamHI site at. -1832 (SEQ. ID. NO. 2, nucleotide number 1) to the BglII site at +103 (SEQ. ID. NO. 2, nucleotide number 1935) was transferred to 'pTZGUS', that is pTZ18U into which the β-glucuronidase coding sequence and nopaline synthase terminator from pBI101 had been transferred as a HindIII-EcoRI fragment. This created a promoter-GUS translational fusion incorporating six amino acids from the amino terminus of GS3A and nine amino acids derived from polylinker
sequence and the GUS leader (see FIG. 8). This construction retained the HindIII, SphI, PstI and Sail restriction sites of the polylinker upstream of the promoter fragment and was therefore suitable to generate 5' deletions in translational fusion. Digestion with PstI and Sail was followed by incubation for various periods of time with exonuclease III, and subsequently exonuclease VII and T4 polymerase (Murphy and Kavanagh, 1988, Nuc. Acids Res. 16 : 5198) . Deleted plasmids were recircularized using T4 DNA ligase and
transformed into E. coli DH5α. DNA was prepared from 10 ml cultures (Murphy and Kavanagh, 1988, Nuc. Acids Res. 16:
5198), and the extent of deletions determined by dideoxy sequencing. Suitable deletions were excised from pTZ by SphI-EcoRI digestion and transferred to pBinl9 (Bevan, 1984, Nuc. Acids Res. 12: 8711-8721) between the Hindlll and EcoRI sites using a HindIII-SphI adaptor-linker.
7.1.4. PLANT TRANSFORMATIONS
Binary vector constructions were transferred into the disarmed Agrobacterium strain LBA4404 by triparental mating using the procedure described by Bevan (1984, Nuc. Acids Res. 12: 8711-8721). The same mated Agrobacterium were used for both tobacco and alfalfa transformation. Nicotiana tabacum genotype SRI was transformed by a leaf inoculation procedure (Horsch et al., 1985, Science 227: 1229-1231), and regenerated shoots were selected on medium containing 200 μg/ml kanamycin. Primary transformants were maintained in sterile culture and subsequently grown to maturity in soil. TI seeds were sterilized in 10% sodium hypochlorite and germinated in medium containing 100 μg/ml kanamycin and 500 μg/ml carbenicillin. Medicago varia genotype A2 was
transformed using a co-cultivation procedure previously described by Deak et al. (1986, Plant Cell Reports 5: 97- 100). Stem internodes were co-cultivated with Agrobacterium in liquid culture containing 1 mg/l 2,4-D and 0.2 mg/l BAP. Subsequently transformed callus was selected on plates containing the same hormones and also 50 μg/ml kanamycin. Selected callus was recultured in liquid medium without kanamycin and redifferentiated somatic embryos were grown up on plates without hormones and- transferred to soil as soon as substantial root growth was observed. Nodulation was induced on primary transformants by treating roots with 'N' medics VN-1 Rhizobium inoculant supplied by Liphatech
(Milwaukee, Wisconsin, USA).
7.1.5. ANALYSIS OF GUS EXPRESSION
Histochemical staining of tissues was done as
previously described (Jefferson, 1987, Plant Mol. Biol. Rep. 5: 387-405; Jefferson et al., 1987, EMBO J. 6: 3901-3907). After incubation with the GUS substrate, 5-bromo-4-chloro-3-indolyl-β-D-glucuronic acid (Clontech), cross-sections of organs and seedlings were cleared of chlorophyll by
incubation with a solution of 5% formaldehyde, 5% acetic acid, and 20% ethanol for 10 minutes followed by 2 minute incubations with 50% and 100% ethanol. For thin sections material was embedded in 'Paraplast Embedding Medium'
(Oxford Labware, St. Louis, Missouri, USA), and 8 μm
sections cut and stained briefly with erythrosin (Berlyn and Miksche, 1974, Botanical Microtechnique and Cytochemistry, Ames, Iowa; Iowa State Univ. Press). Photomicrographs were taken with a Nikon Optiphot microscope using phase-contrast optics.
Fluorometric GUS enzyme assays were done as previously described (Jefferson et al., 1987, Plant Mol. Biol. Rep. 5: 387-405). Five μg of protein were incubated with 4-methylumbelliferyl glucuronide (MUG) solution for 15 minutes after which 2.5 ml of 0.2 M sodium carbonate were added. Fluorescence was measured with a Perkin Elmer LS5
fluorimeter. Fluorescence of a solution of 0.1 mM 4-methylumbelliferone (MU) in 0.2 M sodium carbonate was used for calibration. 7.1.6. DNA MOBILITY SHIFT ANALYSIS
Fragments for DNA mobility-shift analysis were synthesized as oligonuσleotides, and complementary
oligonucleotides annealed and cloned into pTZ19U derived vectors. Fragments were excised from the vector, purified by polyacrylamide gel electrophoresis, and then end-labelled with 32P-dATP, 32P-dCTP, 32P-dGTP, 32P-TTP using the Klenow enzyme. DNA-protein binding was done for 30 minutes at room temperature in 20 mM Hepes-KOH pH 7.5, 40 mM KCl, 1 mM EDTA, 10% glycerol (Katagiri et al., 1989 Nature 340: 727-730). Five μg sonicated polydldC (Pharmacia) was used as non- specific competitor DNA. Whole-cell and nuclear extracts were prepared as previously described (Green et al., 1987, EMBO J. 6: 2543-2549; Green et al., 1989, Plant Molecular Biology Manual Bll, pp. 1-22.
7.2. RESULTS
7.2.1. GS3A PROMOTER SEQUENCE AND DETERMINATION
OF THE TRANSCRIPTIONAL START SITE
A genomic clone was isolated using the GS341 cDNA
(Tingey et al., 1987, EMBO J. 6: 1-9) as a hybridization probe; based upon sequence analysis, was subsequently shown to encode the GS3A gene. Figure 5B shows the sequence of the GS3A promoter extending from -1832 relative to the start of transcription to +107 (SEQ. ID. NO. 2 , numbers 1 to
1939). S1 analysis located the start of transcription to both of two adenosines underlined in FIG. 5B. For the purposes of consistency we notate the second A as +1 (SEQ. ID. NO. 2 , nucleotide number 1833). The transcriptional start site was mapped using RNA from several organs to determine if transcription initiation was identical in organs as diverse as cotyledons and root nodules. The results of this analysis indicate that identical
transcription start sites are utilized in leaves, roots, nodules, and cotyledons (FIG. 7).
7.2.2. DELETION ANALYSIS OF THE GS3A PROMOTER
IN TRANSGENIC ALFALFA AND TOBACCO
A series of 5' promoter deletions of GS3A were ligated to GUS and introduced into tobacco and alfalfa by Ti-mediated DNA transfer. Deletions were made in translational fusion at +107 (SEQ. ID. NO. 2 at 1939) using the BglII site, and therefore include 19 bp of the GS coding sequence (FIG. 8). As described in Section 6, supra, a translational fusion of -903 bp (SEQ. ID. NO. 2 at 929) assayed in
transgenic tobacco was found to confer phloem-specific expression. Our aim was to assess the expression, pattern of GS3A promoter fragments up to approximately 2000 bp driving ø-glucuronidase expression, to identify which promoter elements were responsible for the phloem-specific expression pattern, and to compare this activity to the expression pattern found in the legume alfalfa, in particular in alfalfa nodules.
All six promoter deletion constructions of GS3A assayed in transgenic plants conferred the identical pattern of GUS expression. In tobacco the full-length GS3A promoter construction (FIG. 8, A28), as well as five deletions
(FIG. 8, A45, A22, A16, A13, A10), were found to confer GUS expression in phloem cells in leaves, stem, and roots of primary transformants. These same constructs also conferred vasculature-specific expression in cotyledons and in root tips of TI seedlings (FIG. 9). Transgenic alfalfa plants were produced using four of these constructions (A28, A22, A13, and A10). All four constructs expressed GUS, and expression was again localized to the phloem cells of the leaf (FIG. 10F), stem (FIG. 10G), and root (FIG. 10C) vasculature, and additionally to root tips. Following nodulation, expression was observed in developing nodules. The GS3A promoter directed GUS expression at early stages of nodule formation in the nodule primordia (FIGS. 10A and 10B), and as nodule development proceeded, GUS expression was highest in the meristem and early symbiotic zones and undetectable in the senescent zone (FIGS. 10C, 10D, 10J, 10K and 10L). GUS expression was also visible in the vascular elements around the central infection zone (FIG. 10E).
Control nodules formed on plants transformed with pBI101 showed no GUS expression (FIG. 101).
The comparative analysis of GS3A deletion
constructions in transgenic tobacco and alfalfa revealed that the cis-elements responsible for the expression
patterns observed are conserved between legumes and nonlegumes, and are contained in the smallest deletion
extending to -132 relative to the start of transcription (SEQ. ID. NO. 2, number 1701). Furthermore, the -132 GS3A promoter deletion confers expression in phloem cells of leaves, stems, roots, cotyledons, and nodules, in root tips and also in the meristem and symbiotic zone of nodules.
This 132 bp promoter fragment may therefore contain a single cis-element which activates transcription in phloem,
meristem, and the infected cells of nodules, or
alternatively it may contain multiple elements.
Quantification of GUS expression in leaf, stem, root, cotyledon, and nodule tissue using the GUS fluorometric assay demonstrated that expression was always strongest in nodules, and on average approximately ten times higher than that observed in leaves. Stems and roots showed
intermediate expression (see Table II). TABLE II
FLUORIMETRIC QUANTIFICATION OF GUS ACTIVITY
Organ GUS ACTIVITY*
1 2 3 4 5 6 7 leaf 1800 414 26 238 101 150 455 stem 7480 97 9 mv 26 730 1668 root 9372 339 84 207 268 mv 2054 nodule 13275 708 937 4088 2077 mv 4217
* Values of GUS activity for leaf, stem, root, and nodules from 6 alfalfa transformants are expressed in pmol of MU per mg protein per minute. Transformants 1 and 2 are A28 constructions, and 3, 4, 5, and 6 are A13 constructions. Column 7 expresses tissue means; mv - missing value.
7.2.3. A DNA ELEMENT WITHIN THE GS3A -132 PROMOTER
BINDS TO A FACTOR PRESENT IN PLANT EXTRACTS DNA elements contained within the -132 GS3A promoter were used in DNA mobility-shift assay to identify DNA binding proteins in plants extracts which may play a role in the transcriptional activation of the gene. Mobility-shift assays were undertaken with radio-labelled DNA fragments spanning the -132 GS3A promoter; these fragments are shown
FIG. 11. Fragment a201, which extends from -129 to -97 relative to the start of transcription (SEQ. ID. NO. 2, from nucleotide number 1704 to 1736), was found to bind a factor which was designated GS3A-F1. GS3A-F1 was present in whole-cell extracts of pea, and nuclear extracts of pea and tobacco; it was sensitive to boiling and treatment with proteinase K, indicating the proteinaceous nature of GS3A- F1. Fragments a202 (-129 to -106; SEQ. ID. NO. 2, 1704- 1736) and a206 (-122 to -106; SEQ. ID. NO. 2, 1711 to 1727) also bound GS3A-F1, although a206 exhibited lower affinity (FIG. 11B). In all cases, self-competition with unlabelled fragment was effective at relative molarities of between 10 and 50-fold excess. In cross-competition experiments, unlabelled fragment a202 was able to compete for factor binding to radio-labelled a206 (FIG. 11B). The binding of GS3A-F1 was shown to be specific for its target sequence within a201, in that unlabelled DNA competitor corresponding to the DNA binding sites of cloned transcription factors were unable to compete with a201 for GS3A-F1 binding. Data for competitions with the rbcS-3A GT1 binding site and corresponding mutant are shown in FIG. lie (Green et al., 1988 EMBO J. 7: 4035-4044). Additionally, binding to GS3A-F1 was not competed by the DNA binding sites of 3AF1 or ASF1 (Lam et al., 1990, Plant Cell 2: 857-866; Katagiri et al., 1989, Nature 340: 727-730).
The overlapping region of a202 and a206 is a core of 17 nucleotides which contains an imperfect inverted repeat. Fragment a206 contains an imperfect palindrome, and this was bisected by fragments a230 (-173 to -114; SEQ. ID. NO. 2, 1660 to 1719) and a239 (-113 to -54; SEQ. ID. NO. 2, 1720 to 1779), neither of which were able to bind GS3A-F1. However, when used as unlabelled competitors, both a230 and a239 were able to decrease the binding of GS3A-F1 to a201 and a202 (FIG. 11). This analysis shows that a minimum of 17 bp of the GS3A promoter from -122 to -106 (SEQ. ID. NO. 2, 1711 to 1727) relative to the start of transcription are required for GS3A-F1 binding. This result may provide an insight into the mode of binding of GS3A-F1. It is possible, for example, that a stable DNA-protein complex forms only when GS3A-F1 binds as a dimer to the target DNA and that the 17 bp imperfect palindrome provides a secondary structure to enable such binding. Unlabeled a230 and a239 may compete for monomeric GS3A-F1 and disrupt complex formation without themselves forming a stable interaction with GS3A-F1 detectable by DNA mobility shift assay.
7.3. DISCUSSION
Using the GUS reporter gene, the experiments described in the examples herein demonstrate that the pea GS3A
promoter is expressed in a phloem-specific fashion in both transgenic tobacco and in transgenic alfalfa. The pattern and degree of promoter activity is reflective of glutamine synthesis in phloem cells and the significance of glutamine as a long-distance nitrogen transport compound; i.e., the GS3A gene is expressed at highest levels in pea organs where large amounts of nitrogen are mobilized. Quantification of GUS expression demonstrated that GS3A activity was indeed highest in root nodules of transgenic alfalfa. Expression in nodules was found not only in the vasculature but also in the meristem and the symbiotic zone, where Rhizobia actively fix atmospheric nitrogen; expression was substantially lower in the senescent zone of the nodule in which fixation no longer occurs. Apart from expression in root tips, the activity of the promoter was localized to the phloem cells of the vasculature in all organs examined.
The pattern of GUS expression conferred by the GS3A promoter in transgenic alfalfa differs from that described for GS promoters from Phaseolus vulgaris and soybean GS when introduced into transgenic Lotus corniculatus. Expression of the Phaseolus vulgaris gln-γ gene in Lotus corniculatus was restricted to infected cells of the nodule. The gln-β gene promoter of Phaseolus directed GUS expression in cortical and infected cells of young nodules, and became restricted to nodule vasculature in older nodules of transgenic L. corniculatus (Forde et al., 1989, Plant Cell 1: 391-401). A soybean GS promoter induced GUS gene
expression in the central infected zone (including the uninfected cells) of transgenic L. corniculatus (Miao et al., 1991, Plant Cell 3: 11-22). Since glutamine synthesis and transport may vary in amide (pea, alfalfa, Lotus) and ureide transporting plants (soybean, Phaseolus), the
selection of a specific host plant may influence the
regulation of a heterologous GS promoter. Alfalfa was selected as the host legume for the transgenic studies described infra as it possesses determinate nodules similar to those of pea, and both pea and alfalfa are
physiologically similar in transporting nitrogen primarily as the amides glutamine and asparagine (Pate et al., 1969, Planta 85: 11-34; Newcomb, 1976, Can. J. Bot. 54: 2163-2186; Newcomb, 1981, Int. Rev. Cyt. Suppl. 13: 247-297). The striking feature of GS3A promoter-GUS expression in our experiments is the high level expression in the nodule meristem of transgenic alfalfa. In this context it is interesting that a persistent meristem is one of the
morphological features conserved amongst plants with
indeterminate nodules (e.g. pea and alfalfa).
By promoter deletion analysis we were able to define the region of the GS3A promoter involved in its phloem-specific, cell-specific and developmentally-regulated expression. A short DNA element of GS3A (position -132 to +107 indicated in FIG. 5B; SEQ. ID. NO. 2 nucleotide numbers 1701 to 1939) was functional in both tobacco and alfalfa and was qualitatively equivalent to the full-length promoter in its expression. DNA fragments a201, a202 and a206 contained within the -132 GS3A promoter element (shown in FIG. 11A) were found to bind a proteinaceous factor, GS3A-F1, found in whole-cell extracts of pea, and nuclear extracts of pea and tobacco.
The results described above indicate that the cis-regulatory sequences of the GS3A gene, which function to promote expression in nodules, are also able to promote high level expression in cotyledons, suggesting that the
transcription factors involved in promoting gene expression are not confined to nodules. This is consistent with our observation that the same transcription initiation site is utilized in cotyledons and nodules. Furthermore, it is compatible with the finding that at least one nuclear protein factor which interacts with the GS3A promoter
(GS3A-F1) is present in both pea and tobacco extracts.
The high level of expression of GS3A in cotyledons and nodules suggests that a common signal induces GS expression in these organs. The generation of catabolic ammonia has previously been suggested as a metabolic inducer of GS gene expression (Miao et al., 1991, Plant Cell 3: 11-22; Hirel et al., 1987, EMBO J. 6: 1167-1171). It has been reported that ammonia regulates the expression of GS in soybean
(Hirel et al., 1987, EMBO J. 6: 1167-1171), and more
recently Miao et al. (1991, Plant Cell 3: 11-22) have demonstrated that the promoter of a soybean GS gene was able to confer ammonia inducible expression in transgenic plants. By contrast, analysis of GS expression in fix-nodules demonstrates that ammonia is not required for induced expression of GS in nodules of pea, Phaseolus, and alfalfa (Walker and Coruzzi, 1989, Plant Physiol. 91: 702-708; Cock et al., 1990, Plant Mol. Biol. 14: 549-560; Dunn et al., 1988, Mol. Plant-Microb. Interact. 1: 66-74). Furthermore, our finding that the GS3A-GUS transgene is expressed in nodule primordia formed long before the onset of nitrogen- fixation corroborates the conclusion that newly fixed ammonia is not required for activation of GS3A transcription in nodules.
A further possibility is that GS gene expression is mediated by plant hormones in both nodules and cotyledons. It is curious that the 17 bp element of the GS3A promoter contained within a206 (indicated in FIG. 5B; SEQ. ID. NO. 2 from 1711 to 1727) which binds the protein factor GS3A-F1 is itself palindromic and similar to the palindromic mammalian steroid response element (Evans, 1988, Science 240: 889- 895). This homology is intriguing because GS expression in animals has been shown to be steroid-induced in at least one mammalian cell line (Miller et al., 1978, Proc. Natl. Acad. Sci. USA 75: 1418-1422). The factor GS3A-F1 is present in both pea and tobacco extracts and this is consistent with the activity of the GS3A promoter in both these species. We also note the existence of a sequence with homology to the previously described nodulin consensus (Forde et al., 1990, Plant Cell 2: 925-939) at nucleotides -106 to -101; this sequence was not, however, involved in the binding of GS3A-F1 or any other factor that we were able to detect in plant extracts.
8. DEPOSIT OF MICROORGANISMS
The following microorganisms have been deposited with the Agricultural Research Culture Collection, Northern
Regional Research Center (NRRL) and have been assigned the following accessin numbers:
Microorganism Plasmid Accession No.
Escherichia coli XL1 pGS2ct-1/1583 B-18575
Escherichia coli XL1 pGS3Acy-1/1941 B-18576
Escherichia coli XL1 pGS3Acy-931/1941 B-18577
Excherichia coli XL1 pGS3Bey-1/1248 B-18578 The present invention is not to be limited in scope by the specific embodiments described herein. Indeed, various modifications of the invention in addition to those described herein will become apparent to those skilled in the art from the foregoing description and accompanying figures. Such modifications are intended to fall within the scope of the appended claims.
Various publications are cited herein, the
disclosures of which are incorporated by reference in their entireties.
SEQUENCE LISTING
(1) GENERAL INFORMATION:
(i) APPLICANT: CORUZZI, GLORIA M
EDWARDS, JANICE W
WALKER, ELSBETH L
BREARS, TIMOTHY B
(ii) TITLE OF INVENTION: NOVEL ORGAN-SPECIFIC PLANT PROMOTER
SEQUENCES
(iii) NUMBER OF SEQUENCES: 3
(iv) CORRESPONDENCE ADDRESS:
(A) ADDRESSEE: PENNIE & EDMONDS
(B) STREET: 1155 AVENUE OF THE AMERICAS
(C) CITY: NEW YORK
(D) STATE: N.Y.
(E) COUNTRY: U.S.A.
(F) ZIP: 10036
(v) COMPUTER READABLE FORM:
(A) MEDIUM TYPE: Floppy disk
(B) COMPUTER: IBM PC compatible
(C) OPERATING SYSTEM: PC-DOS/MS-DOS
(D) SOFTWARE: Patentln Release #1.0, Version #1.25
(vi) CURRENT APPLICATION DATA:
(A) APPLICATION NUMBER: US
(B) FILING DATE: 13-JUN-1991
(C) CLASSIFICATION:
(viii) ATTORNEY/AGENT INFORMATION:
(A) NAME: MISROCK, S. LESLIE
(B) REGISTRATION NUMBER: 18,872
(C) REFERENCE/DOCKET NUMBER: 3288-017-999
(ix) TELECOMMUNICATION INFORMATION:
(A) TELEPHONE: (212) 790-9090
(B) TELEFAX: (212) 869-9741
(C) TELEX: 66141 PENNIE
(2) INFORMATION FOR SEQ ID NO:1:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 1601 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS : single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: DNA (genomic)
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1:
CTATACTACG TGGAATTCAG AAAGGAAAGG GAAAGACTCT TCAGATGTTG GAAGCAAGGA 60
AGAGGCCTAT ATAAAGGACA TGAAGAAATG AGGAATATGT GGGCGCAGAA TCACATGAGA 120
AAATACTTGA ATACACTTAA ATCAATTATT TTTATACTCT CCTTGACGAA TAACGGGGAA 180
GTCAACCTTT TAGTATTTTT ACCAAGAATA CACAAATAAA TAGAATCTAA TTCTTTTAAT 240
AGAAATCAAT TATCCGAGTC ACACAATTGC TGCGATTAAT TTCTCGAGTA GAATTTGATT 300
AAAACTAAAT ATACATAAAT GAGTGAGAAC ACCAAATAAA TAAAATTATA AAAAATAATA 360 TTATAATGTA TTAAGATGAT AAAGTATAAT TAACTTTAGA CTTAAATGAG TTTTTTTTTT 420
ACTCTTCCAT TATTTTATTT GGAGTTTCCC CCCATTTTTT AAATCCCAAA ATAATGTTAC 480
TTATGTGCTA ATTTGTCAAA TCATAGTTTT GATATTAAAA TTTTCAAATA TATTGTAATG 540
CTACATAAGT TTCACGTGCA TTATTTCTCA ATCATCATAT TTACTACTAA ATGTTAAAAT 600
TTGACATAGA AATCAAAATT GTATAAATTC AAAAACTATA -TAATCATAAT TGCAAATTAA 660
TGTTTCTAAG CAAAGCAACT TAAGTTAAGA AGATCTAAGC AAAGATACAA AGATATTGTC 720
AACATAGAAT TTAGTAATCA TTATTCATTG TAGTTATAGA ATCTAAACAT GAAAATTAAT 780
TGGATAAAAA AAGAAAGAGA AATCCTTATC TAAATATTGA AAGTCCAAGC TTCTCTTGGT 840
GCTCTTTAAG GGACCAAAAA CAAACTTCAT CCACTCAAAA ACTCACCCCT ATCGTTATTG 900
CAATAGCCAA CAAACTTGTT TTCTTGCCCA CCACCAACCC TTATTTTACA CAACTCTCTC 960
TCACTCTCTA TTGCTCCATT GACACAAGGC TCATTCTCAC TTGAACCCAT TTTCAACCTT 1020
TGCTGTTTTT GCCATTTTTC AACTCTGTAT TGGTGAGTTT CTTTCTACCT TCAATACCAT 1080
TTTCGTCCTT TTTCTTAAAC GTTTATTTAT GACATTCAAA ATTCAATCTT TGTAGTTTCT 1140
TGCTAGTGAA AATTTATGAT GGTTCTTTGA ATATACTTTA GCTTCATGCA AAACTAACTT 1200
CTTTATCATT TTGAGCAAAT TGATGTTTAG TAGCTATGAA AGAATTTGGA TCTGATTAAT 1260 CACTTTGTTT TATTGTGTTA TATCTAAATA TGATTCCAAA AAGCAATGCT CTTGGTAAAC 1320
TTTACTCTCT TTTATGTTAG TTAGATATTT TCTTGAATGA TTATTTACTT CTTGGTTGGT 1380
TTTTTGCAAT GTGCATCTTA ATAGAATGCT GTTTGATTCT TTTTTTTTTT GTTGAGTAGA 1440
AAATGGCGCA GATTTTGGCA CCTTCGACGC AATGGCAGAT GAGAATCACA AAAACCTCTC 1500
CTTGTGCAAC TCCAATCACA TCAAAGATGT GGAGTTCTTT GGTTATGAAA CAAACTAAGA 1560
AAGTTGCGCA TTCTGCTAAA TTTAGAGTTA TGGCAGTCAA C 1601 (2 ) INFORMATION FOR SEQ ID NO: 2 :
( i ) SEQUENCE CHARACTERISTICS :
(A) LENGTH: 1939 base pairs
(B) TYPE: nucleic acid
( C) STRANDEDNESS : single
( D ) TOPOLOGY : linear
( ii ) MOLECULE TYPE : DNA (genomic )
( xi ) SEQUENCE DESCRIPTION : SEQ ID NO : 2 :
GATCCTCTAG CCTATCAAGG AGTAATATCT ATCATATCTA ACTCTGGACC CATTTACTTG 60
GATCTAGTTA GAGAATTTTA TGTAAATTTA TCAATTGGTA CTGGGTGC&T TTTGTAATCA 120
AAAGTGAAGG ACAAAAATAC TGTAAATTTA TCAATTGGTA ATGGACATGA CAAAGTACCT 180
AATTCACCCC TCCCTCCTCT TAGGTGCATT CCATACTTAC AATAGTTTAT ATAATTGGAT 240
TGGACATAAC ATCGATGGTG GCTCTACCTT TTTGGTTGCT TGCTGATAGT TGCGTTGCGC 300
TAGGAACAAA TTGTGTCTTG CTAATGAAAT TGTATCTTCA TATACTTTGA AACTCATAAC 360
AATGAATTGT GCTAATCTGT TAGCTAAATG TTTTCTCAAG CAGTGTCTTA TCTAATTAGA 420 ACGATCACGT GGAATGCACA CAAAGGTAGT AATATAATTT TGAATGTTAA TGACAGTAGC 480
CTCAGTAATC CCGACGTCTC AAGTTTTGGT GGGTTGATTT GAAGTGTTGA TGGTGTTTGG 540
GTTCACGATT TTGTGGGTAA TATTGGTTAT TCCAATATCC TTCATGTTGA GTGATTGCAT 600
TATATCATGC TTTGTGTATG ACCTAAAAAC TTGGCCAGTG AAGACTTGAG GTGTTATTCT 660
AACTCCAACT CTATTATCAA GCTTATCACA TAGTCGGTTA 'ATGTTTAACA TCACTGTGCT 720
GCTAATCTTC ACAATATTAA AAAACTGGTC TCTTAGGAAT GCCGGGTTCA AATATTTCTA 780
CTCTTAGGAA GAAGAATGTT TGTGTTGACT ATCTAGCAAA ACATGGAACT GACAATGATG 840
CGGCGTACCA GTCTTTTGCA GAGCCTACTA TAGGAATCAT CACTCACTTA CTAGTTGGCG 900
CTAGTGAGAT TTTATTTTTT AAATAATTTT TTTTCTTTTC CTTTTTTACT TGTACAAAAA 960
AAATATTCAA GTTCAAAAAA AAAGAAAAAA AATTATTTGA ATTTAAAATA AAAATCAAAA 1020
ATGAAAAATC AAATAAAATA GAGAACACTA TTTTCAATTA AATTCTTTTA TTAAATACAT 1080
GAATAAAAAC TAAATAATAT AATAATGATC TTTAACTTTA AATACTAATT CATATAATAA 1140
TAAAAACTAA CTATAAGAAT ACTAACAATA AACTTTAATT GCTTTATTAA GTCATCTATA 1200
ATAGAGAAAT TCAATAATAA CAAGTTTGAA TTGTGAAATT TTGATTATTA GATACTAAAG 1260
AGTGAAATTT TAATTATTAG ATATTTAATA AAAATATTAT TTTAAAATAG TATACTTTAA 1320 TTTGAATTAA TATTTAAAGT TGTATTACAT AGAACTTTAC AAATGCTAAA TAAAATTATT * 1380
TTGAATCAAA ATATAAAATA AATATAATAT AGTTTTACCA AAAAAAAAAT ATTAATTAAG 1440
TGAAGTATCC TACCAACCAC ATATTAATTA GATAATTATA TTAAAAAACA TACTTTTCCG 1500
TACATTGCTT CTCATAAAAA TATCATTTAT CTATAAGACA GAATCATATC TACACCGCAA 1560
ATTATTCTCA TTAGATTCGT AAAAGAAATT CAAAGTTATC ATATCCTTTC CTTTTCTTTT 1620
AGAAAAAAAT TAAGTGATAA TCTATTTTAT TTCATTTCTA TCTTTAAGAA ATTAAAAAAT 1680
AACCATTTTA TTCCAATTTT CAAAATTCAA TTGATCTAGT AGATAAAAAG ATTCTCCGAA 1740
GACAACCACT AAAAAGTTAA TAACAATTTA ATAGTAATTT TTTCTACATA TCATTCTATT 1800
ATAAATAGGT TCATATCTCA CACTTTCTTT TAACCCTTAC AAAAAGCCAG AGATTCCTCT 1860
GTAGCTATCT TTCAACAAAA CCGCGTTCTT CTTTTTCCTT CAAAGCTTTT CATTATCATT 1920
ATGTCTTCAC TTTCAGATC 1939 (2) INFORMATION FOR SEQ ID NO: 3:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 1262 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS : single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: DNA (genomic)
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 3:
GTTAAACACT GCTGCAGAAT ATGACTATGG GCTCTAAAGA AAGCTTCAAA GAATATGCTC 60 AAAAATGGAG AGACTTGGCT GACAGAGTCA AACCCCCTAT GACTGATCGA GAATTAGTGG 120 ACATGTTCAT GGGTACACTG ACTGGCCCAT TCTACAGCCA TATATTGGGA AGTTCCTCAT 180
CGGGTTTCAC TGAACTTATA TTTACGGGTG AACGTGTTGA ACGCGGCATT CGAAGTGGAA 240
AGATACATGC GGCTACCTCT GCAAGCACAA AAAAGTCCTA TCAAGGGAAG AATGAATCAA 300
ATGCTGTGTA CGGTCAAAGG GGTCATAACA AGAAAAATCG TGACCATACT GTTGGAGCAG 360
TTACGATTGC AGCACCGCCA TCTCAAAACT TCCAACACAG ACAAGACAGG CCAAGAAGGC 420
AGTTTACCAA GATCAATATG ACTTTAGCAC AAGCACTGTA GGGTATGCTA AAAGCAAATT 480
TAATTACCCT CAGAGATCCT CCTGCAAATC CCAACACTAC TTCTCCTCGT TATAATCCCA 540
ATGCCAGGTG TGCATATCAC TCCGATAGCC CCGGGCATGA TACAAACGAT TGTTGGTTGT 600
TGAAGAATAA GATTCAGGAT ATGATCGACG CTGGAGAAAT TGAATTTGAT CCTTCGGAGA 660
CTCCTAATGT CATCACTGCT CCAATGCCTA ATCATAACAA GACTATTAAT GTTGTGGATG 720
ACATACTTAA AAAATATTCT TTTTCATACA TATTAATTAA ATGAAGTATC CTACCAACCA 780
CATATTAATT AAATAATTAT ATTAAAAAAC ATACTTTTTC ATACATTGCT TCTCATAAAA 840
ATATCATTTA TCTATAAGAC AGAATCATAT CTACACCGCA AATTATTCTC ATTAGATTCA 900
TAAAAGAAAT TCAAAGTTAT CATATCCTTT CCTTTTCTTT TAGAAAAAAA TTAAGTGATA 960
ATCTATTTTA TTTCATTTCA ATCTTTAAGA AATTAAAAAA TAACCATTTT ATTCAATTTT 1020
CAGAATTCAA TTCATCTAGT AGATAAAAAG ATTCTCCTAA CACAACCACT AAAAAGTTAA 1080
TATCAATTTA GTAGTAATTT TTTCTACATA TCATTCTATT ATAAATAGGT TCATATCTCA 1140
CACTTTCTTT TAACCCTTAC AAAAAGCCAG AGATTCCTCT GTAGCTATCT TTCAACAAAA 1200
CGCGTTCTTC TTTTTTCTTC AAAGCTTTTC ATTATCATTA TGTCTTCACT TTCAGAAGAT 1260
CT 1262
Figure imgf000060_0001
Figure imgf000061_0001

Claims

WHAT IS CLAIMED IS:
1. A substantially pure GS2 promoter element.
2. The substantially pure GS2 promoter element of Claim 1 comprising a nucleotide sequence substantially as depicted in Figure 5A from nucleotide residue number 1 to 1424, or SEQ. ID. NO. 1 from nucleotide residue number 1 to 1471.
3. A recombinant DNA molecule containing a GS2 promoter element.
4. The recombinant DNA molecule of Claim 3 in which the GS2 promoter element comprises a nucleotide sequence substantially as depicted in Figure 5A or SEQ. ID. NO. 1 from nucleotide residue number 1 to 1471.
5. A recombinant gene fusion comprising a nucleotide sequence which encodes a desired gene product controlled by a GS2 promoter element.
6. The recombinant gene fusion of Claim 5 in which the GS2 promoter element comprises a nucleotide sequence substantially as depicted in Figure 5A from nucleotide residue number 1 to 1424, or SEQ. ID. NO. 1 from nucleotide residue number 1 to 1471.
7. A transgenic plant containing a transgene
controlled by a GS2 promoter element.
8. The transgenic plant of Claim 7 in which the GS2 promoter element comprises a nucleotide sequence
substantially as depicted in Figure 5A from nucleotide residue number 1 to 1424, or SEQ. ID. NO. 1 from nucleotide residue number 1 to 1471.
9. The transgenic plant of Claim 7 in which the transgene encodes a product that renders the plant resistant to viral infection.
10. The transgenic plant of Claim 9 in which the transgene comprises a nucleotide sequence which encodes a viral coat protein.
11. The transgenic plant of Claim 7 in which the transgene encodes a product that renders the plant resistant to a herbicide.
12. A substantially pure GS3A promoter element.
13. The substantially pure GS3A promoter element of Claim 12 comprising a nucleotide sequence substantially as depicted in Figure 5B from nucleotide residue -1832 to -1, or SEQ. ID. NO. 2 from nucleotide residue number 1 to 1832.
14. The substantially pure GS3A promoter element of Claim 12 comprising a nucleotide sequence substantially as depicted in Figure 5B from nucleotide residue number -132 to number -1 or SEQ. ID. NO. 2 from nucleotide residue number 1701 to 1832.
15. The substantially pure GS3A promoter element of Claim 12 comprising substantially the following nucleotide sequence shown in SEQ. ID. NO. 2 from nucleotide residue number 1704 to 1736:
AAATTCAATTGATCTAGTAGATAAAAAGATTC.
16. The substantially pure GS3A promoter element of Claim 12 comprising substantially the following nucleotide sequence shown in SEQ. ID. NO. 2 from nucleotide residue number 1704 to 1727:
AAATTCAATTGATCTAGTAGATAAAAA.
17. The substantially pure GS3A promoter element of Claim 12 comprising substantially the following nucleotide sequence shown in SEQ. ID. NO. 2 from nucleotide residue number 1711 to 1727:
TTGATCTAGTAGATAAA.
18. A recombinant DNA molecule containing a GS3A promoter element.
19. The recombinant DNA molecule of Claim 18 in which the GS3A promoter element comprises a nucleotide sequence substantially as depicted in Figure 5B from nucleotide residue -1832 to -1, or SEQ. ID. NO. 2 from nucleotide residue number 1 to 1832.
20. The recombinant DNA molecule of Claim 18 in which the GS3A promoter element comprises a nucleotide sequence substantially as depicted in Figure 5B from nucleotide residue number -132 to number -1 or SEQ. ID. NO. 2 from nucleotide residue number 1701 to 1832.
21. The recombinant DNA molecule of Claim 18 in which the GS3A promoter element comprises substantially the following nucleotide sequence shown in SEQ. ID. NO. 2 from nucleotide residue number 1704 to 1736:
AAATTCAATTGATCTAGTAGATAAAAAGATTC.
22. The recombinant DNA molecule of Claim 18 in which the GS3A promoter element comprises substantially the following nucleotide sequence shown in SEQ. ID. NO. 2 from nucleotide residue number 1704 to 1727:
AAATTCAATTGATCTAGTAGATAAAAA.
23. The recombinant DNA molecule of Claim 18 in which the GS3A promoter element comprises substantially the following nucleotide sequence shown in SEQ. ID. NO. 2 from nucleotide residue number 1711 to 1727:
TTGATCTAGTAGATAAA.
24. A recombinant gene fusion comprising a nucleotide sequence which encodes a desired gene product controlled by a GS3A promoter element.
25. The recombinant gene fusion of Claim 24 in which the GS3A promoter element comprises a nucleotide sequence substantially as depicted in Figure 5B from nucleotide residue -1832 to -1, or SEQ. ID. NO. 2 from nucleotide residue number 1 to 1832.
26. The recombinant gene fusion of Claim 24 in which the GS3A promoter element comprises a nucleotide sequence substantially as depicted in Figure 5B from nucleotide residue number -132 to number -1 or SEQ. ID. NO. 2 from nucleotide residue number 1701 to 1832.
27. The recombinant gene fusion of Claim 24 in which the GS3A promoter element comprises substantially the following nucleotide sequence shown in SEQ. ID. NO. 2 from nucleotide residue number 1704 to 1736:
AAATTCAATTGATCTAGTAGATAAAAAGATTC.
28. The recombinant gene fusion of Claim 24 in which the GS3A promoter element comprises substantially the following nucleotide sequence shown in SEQ. ID. NO. 2 from nucleotide residue number 1704 to 1727:
AAATTCAATTGATCTAGTAGATAAAAA.
29. The recombinant gene fusion of Claim 24 in which the GS3A promoter element comprises substantially the following nucleotide sequence shown in SEQ. ID. NO. 2 from nucleotide residue number 1711 to 1727:
TTGATCTAGTAGATAAA.
30. A transgenic plant containing a transgene controlled by a GS3A promoter element.
31. The transgenic plant of Claim 30 in which the GS3A promoter element comprises a nucleotide sequence substantially as depicted in Figure 5B from nucleotide residue -1832 to -1, or SEQ. ID. NO. 2 from nucleotide residue number 1 to 1832.
32. The transgenic plant of Claim -30 in which the GS3A promoter element comprises a nucleotide sequence substantially as depicted in Figure 5B from nucleotide residue number -132 to number -1 or SEQ. ID. NO. 2 from nucleotide residue number 1701 to 1832.
33. The transgenic plant of Claim 30 in which the GS3A promoter element comprises substantially the following nucleotide sequence shown in SEQ. ID. NO. 2 from nucleotide. residue number 1704 to 1736:
AAATTCAATTGATCTAGTAGATAAAAAGATTC.
34. The transgenic plant of Claim 30 in which the GS3A promoter element comprises substantially the following nucleotide sequence shown in SEQ. ID. NO. 2 from nucleotide residue number 1704 to 1727:
AAATTCAATTGATCTAGTAGATAAAAA.
35. The transgenic plant of Claim 30 in which the GS3A promoter element comprises substantially the following nucleotide sequence shown in SEQ. ID. NO. 2 from nucleotide residue number 1711 to 1727:
TTGATCTAGTAGATAAA.
36. The transgenic plant of Claim 30 in which the transgene encodes a product that renders the plant resistant to viral infection.
37. The transgenic plant of Claim 36 in which the transgene comprises a nucleotide sequence which encodes a viral coat protein.
38. The transgenic plant of Claim 30 in which the transgene encodes a product that renders the plant resistant to a herbicide.
39. A substantially pure GS3B promoter element.
40. The substantially pure GS3B promoter element of Claim 39 comprising a nucleotide sequence substantially as depicted in Figure 5C from nucleotide residue number 1 to 1228, or SEQ. ID. NO. 3 from nucleotide residue number 1 to 1239.
41. A recombinant DNA molecule containing a GS3B promoter element.
42. The recombinant DNA molecule of Claim 41 in which the GS3B promoter element comprises a nucleotide sequence substantially as depicted in Figure 5C from nucleotide residue number 1 to 1228, or SEQ. ID. NO. 3 from nucleotide residue number 1 to 1239.
43. A recombinant gene fusion comprising a nucleotide sequence which encodes a desired gene product controlled by a GS3B promoter element.
44. The recombinant gene fusion of Claim 43 in which the GS3B promoter element comprises a nucleotide sequence substantially as depicted in Figure 5C from nucleotide residue number 1 to 1228, or SEQ. ID. NO. 3 from nucleotide residue number 1 to 1239.
45. A transgenic plant containing a transgene
controlled by a GS3B promoter element.
46. The transgenic plant of Claim 45 in which the GS3B promoter element comprises a nucleotide sequence substantially as depicted in Figure 5C, from nucleotide residue number 1 to 1228, or SEQ. ID. NO. 3 from nucleotide residue number 1 to 1239.
47. The transgenic plant of Claim 45 in which the transgene encodes a product that renders the plant resistant to viral infection.
48. The transgenic plant of Claim 47 in which the transgene comprises a nucleotide sequence which encodes a viral coat protein.
49. The transgenic plant of Claim 45 in which the transgene encodes a product that renders the plant resistant to a herbicide.
50. A substantially pure DNA binding protein which binds to the following 17 base pair nucleotide sequence shown in SEQ. ID. NO. 2 from nucleotide residue number 1711 to 1727:
TTGATCTAGTAGATAAA.
PCT/US1992/005170 1991-06-13 1992-06-12 Novel organ-specific plant promoter sequences WO1992022582A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP92915003A EP0590086A4 (en) 1991-06-13 1992-06-12 Novel organ-specific plant promoter sequences.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/715,751 US5391725A (en) 1989-12-08 1991-06-13 Organ-specific plant promoter sequences
US715,751 1991-06-13

Publications (1)

Publication Number Publication Date
WO1992022582A1 true WO1992022582A1 (en) 1992-12-23

Family

ID=24875334

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1992/005170 WO1992022582A1 (en) 1991-06-13 1992-06-12 Novel organ-specific plant promoter sequences

Country Status (4)

Country Link
US (1) US5391725A (en)
EP (1) EP0590086A4 (en)
AU (1) AU2261092A (en)
WO (1) WO1992022582A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999038990A1 (en) * 1998-01-30 1999-08-05 Board Of Trustees, Rutgers, The State University Of New Jersey Methods for recovering polypeptides from plants and portions thereof
WO2000011144A3 (en) * 1998-08-19 2000-09-08 Cambridge Advanced Tech Plastid-targeting nucleic acid sequence, beta-amylase sequence, a stimulus-responsive promoter and uses thereof

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5495007A (en) * 1994-04-29 1996-02-27 Thompson; Gary A. Phloem-specific promoter
US5981703A (en) * 1995-06-07 1999-11-09 New York University Plant glutamate receptors
GB9703146D0 (en) * 1997-02-14 1997-04-02 Innes John Centre Innov Ltd Methods and means for gene silencing in transgenic plants
US6777546B2 (en) * 1997-10-07 2004-08-17 Loma Linda University Methods and substances for preventing and treating autoimmune disease
US6831040B1 (en) 2000-01-27 2004-12-14 The Regents Of The University Of California Use of prolines for improving growth and other properties of plants and algae
EP1950305A1 (en) 2001-05-09 2008-07-30 Monsanto Technology, LLC Tyr a genes and uses thereof
US7138278B2 (en) * 2001-11-20 2006-11-21 Monsanto Technology, L.L.C. Maize cytoplasmic glutamine synthetase promoter compositions and methods for use thereof
US7566813B2 (en) 2002-03-21 2009-07-28 Monsanto Technology, L.L.C. Nucleic acid constructs and methods for producing altered seed oil compositions
EP1484959A4 (en) 2002-03-21 2005-08-31 Monsanto Technology Llc Nucleic acid constructs and methods for producing altered seed oil compositions
WO2004081204A1 (en) 2003-03-12 2004-09-23 Ishihara Sangyo Kaisha, Ltd. Plant and plant cell having been modified in cell multiplication and development/differentiation
US7807874B2 (en) 2003-12-10 2010-10-05 Monsanto Technology Llc Stress tolerant plants and methods thereof
US7230162B2 (en) * 2003-12-19 2007-06-12 Monsanto Technology Llc CEP1 gene promoter sequences from Zea mays and methods of use
ATE540119T1 (en) 2004-09-13 2012-01-15 Monsanto Technology Llc PROMOTOR MOLECULES FOR USE IN PLANTS
CA2580201A1 (en) * 2004-09-14 2006-03-23 Monsanto Technology Llc Promoter molecules for use in plants
EP1791962B1 (en) 2004-09-24 2012-04-25 Monsanto Technology, LLC Promoter molecules isolated from brassica napus for use in plants
CA2524565A1 (en) * 2004-12-04 2006-06-04 Sungene Gmbh Expression cassettes for mesophyll- and/or epidermis-preferential expression in plants
EP1666599A3 (en) * 2004-12-04 2006-07-12 SunGene GmbH Expression cassettes for mesophyll- and/or epidermis-preferential expression in plants
BRPI0708480A2 (en) 2006-03-02 2011-05-31 Athenix Corp processes and compositions for enhanced enzyme activity in transgenic plants
EP3133162B1 (en) 2006-03-10 2021-04-21 Monsanto Technology LLC Soybean seed and oil compositions and methods of making same
WO2008073578A2 (en) 2006-12-08 2008-06-19 Iowa State University Research Foundation, Inc. Plant genes involved in nitrate uptake and metabolism
CA2681193C (en) 2007-03-16 2016-01-26 New York University Pericycle-specific expression of microrna167 in transgenic plants
US8153863B2 (en) 2007-03-23 2012-04-10 New York University Transgenic plants expressing GLK1 and CCA1 having increased nitrogen assimilation capacity
AU2010287069B2 (en) 2009-08-27 2016-07-07 Pastoral Greenhouse Gas Research Ltd Complete genome sequence of the methanogen Methanobrevibacter ruminantium
AU2015346281B2 (en) 2014-11-12 2021-12-02 Nmc, Inc. Transgenic plants with engineered redox sensitive modulation of photosynthetic antenna complex pigments and methods for making the same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4886753A (en) * 1986-01-28 1989-12-12 A/S De Danske Sukkerfabrikker Method for the expression of genes in plants, parts of plants, and plant cell cultures, and DNA fragments, plasmids, and transformed microorganisms to be used when carrying out the method, as well as the use thereof for the expression of genes in plants
US4962028A (en) * 1986-07-09 1990-10-09 Dna Plant Technology Corporation Plant promotors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4782022A (en) * 1984-06-04 1988-11-01 Lubrizol Genetics, Inc. Nitrogen fixation regulator genes
NZ224787A (en) * 1987-05-26 1990-08-28 Calgene Inc A dna construct for specifically modifying the phenotype of fruit as distinct from other plant tissue
AU7165491A (en) * 1989-12-08 1991-07-18 Trustees Of Rockefeller University, The Novel organ-specific plant promoter sequences

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4886753A (en) * 1986-01-28 1989-12-12 A/S De Danske Sukkerfabrikker Method for the expression of genes in plants, parts of plants, and plant cell cultures, and DNA fragments, plasmids, and transformed microorganisms to be used when carrying out the method, as well as the use thereof for the expression of genes in plants
US4962028A (en) * 1986-07-09 1990-10-09 Dna Plant Technology Corporation Plant promotors

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
LEWIN, ed., "Genes", Second Edition, published 1985 by John Wiley & Sons, pages 469-470, see entire document. *
See also references of EP0590086A4 *
The Journal of Biological Chemistry, Volume 263, No. 20, issued 15 July 1988, TINGEY et al., "Chloroplast and cytosolic glutamine synthetase are encoded by homologous nuclear genes which are differentially expressed in vivo", pages 9651-9657, see entire document. *
The Plant Cell, Volume 1, issued April 1989, FORDE et al., "Two glutamine synthetase genes from Phaseolus vulgaris L. display contrasting developmental and spatial patterns of expression in transgenic Lotus corniculatus plants", pages 391-401, see entire document. *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999038990A1 (en) * 1998-01-30 1999-08-05 Board Of Trustees, Rutgers, The State University Of New Jersey Methods for recovering polypeptides from plants and portions thereof
US6096546A (en) * 1998-01-30 2000-08-01 Board Of Trustees, Rutgers, The State University Of New Jersey Methods for recovering polypeptides from plants and portions thereof
WO2000011144A3 (en) * 1998-08-19 2000-09-08 Cambridge Advanced Tech Plastid-targeting nucleic acid sequence, beta-amylase sequence, a stimulus-responsive promoter and uses thereof
US6489540B1 (en) 1998-08-19 2002-12-03 Advanced Technologies (Cambridge) Limited Plastid-targeting nucleic acid sequence, a novel β-amylase sequence, a stimulus-responsive promoter and uses thereof
CZ303574B6 (en) * 1998-08-19 2012-12-19 Advanced Technologies (Cambridge) Limited Nucleic acid sequence, method of increasing or decreasing in a plant the activity of {beta}-amylase, method of targeting proteins or enzymes to a plant plastid, method of increasing or decreasing amount of starch produced by a transgenic plant, chime

Also Published As

Publication number Publication date
EP0590086A1 (en) 1994-04-06
US5391725A (en) 1995-02-21
AU2261092A (en) 1993-01-12
EP0590086A4 (en) 1995-04-26

Similar Documents

Publication Publication Date Title
US5391725A (en) Organ-specific plant promoter sequences
Edwards et al. Cell-specific expression in transgenic plants reveals nonoverlapping roles for chloroplast and cytosolic glutamine synthetase.
US8288611B2 (en) Nitrogen-efficient monocot plants
KR100228918B1 (en) Chimeric plant genes based on upstream regulatory elements of helianthin
CA2173730C (en) Transgenic plants that exhibit enhanced nitrogen assimilation
EP0729514B1 (en) Chimeric regulatory regions and gene cassettes for expression of genes in plants
CA2633517C (en) Promoter sequence obtained from rice and methods of use
Brears et al. A promoter sequence involved in cell‐specific expression of the pea glutamine synthetase GS3A gene in organs of transgenic tobacco and alfalfa
WO2006036864A2 (en) Promoter, promoter control elements, and combinations, and uses thereof
US20210102218A1 (en) Expression of transcription regulators that provide heat tolerance
WO2006028332A1 (en) Sucrose-inducible promoter from sweetpotato
Franche et al. Transient gene expression in cassava using high-velocity microprojectiles
WO1991009050A1 (en) Novel organ-specific plant promoter sequences
Huang et al. Isolation and functional analysis of Convolvulus arvensis EPSPS promoter

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU BB BG BR CA CS FI HU JP KR LK MG MN MW NO PL RO RU SD

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE BF BJ CF CG CH CI CM DE DK ES FR GA GB GN GR IT LU MC ML MR NL SE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
EX32 Extension under rule 32 effected after completion of technical preparation for international publication

Ref country code: UA

LE32 Later election for international application filed prior to expiration of 19th month from priority date or according to rule 32.2 (b)

Ref country code: UA

LE32 Later election for international application filed prior to expiration of 19th month from priority date or according to rule 32.2 (b)

Ref country code: UA

WWE Wipo information: entry into national phase

Ref document number: 1992915003

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1992915003

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1992915003

Country of ref document: EP